REFERENCES
1. Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 1999;2:861–863.
2. Luna B, Garver KE, Urban TA, et al. Maturation of cognitive processes from late childhood to adulthood. Child Dev 2004;75:1357–1372.
3. Bouchard TJ, Lykken DT, McGue M, et al. Sources of human psychological differences: the Minnesota study of twins reared apart. Science 1990;250:223–228.
4. Dickens WT, Flynn JR. Heritability estimates versus large environmental effects: the IQ paradox resolved. Psychol Rev 2001;108:346–369.
5. Andreasen NC, Flaum M, Swayze V 2nd, et al. Intelligence and brain structure in normal individuals. Am J Psychiatry 1993;150:130–134.
6. Gale CR, O’Callaghan FJ, Godfrey KM, et al. Critical periods of brain growth and cognitive function in children. Brain 2004;127:321–329.
7. Welsh MC, Pennington BF, Groisser DB. A normative-developmental study of executive function: a window on prefrontal function in children. Dev Neuropsychology 1991;7:131–149.
8. Bjork JM, Knutson B, Fong GW, et al. Incentive-elicited brain activation in adolescents: similarities and differences from young adults. J Neurosci 2004;24:1793–1802.
9. Denckla MB. Development of motor coordination in normal children. Dev Med Child Neurol 1974;16:729–741.
10. Kinsbourne M. Development of attention and metacognition. In: Rapin I, Segalowitz S, eds. Handbook of Neuropsychology. Amsterdam: Elsevier Science, 1993:261–278.
11. Mikkelsen EJ, Brown GL, Minichiello MD, et al. Neurological status in hyperactive, enuretic, encopretic, and normal boys. J Am Acad Child Psychiatry 1982;21:75–81.
12. Shaffer SQ, Stockman CJ, Shaffer D. Ten-year consistency in neurological test performance of children without focal neurological deficits. Dev Med Child Neurol 1986;28:417–427.
13. Woods BT, Eby MD. Excessive mirror movements and aggression. Biol Psychiatry 1982;17:23–32.
14. Rao MR, Brenner RA, Schisterman EF, et al. Long-term cognitive development in children with prolonged crying. Arch Dis Childhood 2004;89:989–992.
15. Rutter M. Syndromes attributed to “minimal brain dysfunction” in childhood. Am J Psychiatry 1982;139:21–33.
16. Gillberg C. Deficits in attention, motor control and perception: a brief review. Arch Dis Child 2003;88:904–910.
17. Gillberg C, Rasmussen P. Perceptual, motor and attentional deficits in seven-year-old children. Background factors. Dev Med Child Neurol 1982;24:752–770.
18. Piek JP, Dyek MJ, Nieman A, et al. The relationship between motor coordination, executive functioning and attention in school-aged children. Arch Clin Neuropsychol 2004;19:1063–1076.
19. Shevell MI, Majnemer A, Rosenbaum P, et al. Etiological determination of childhood developmental delay. Brain Dev 2001;23:228–235.
20. Wuu KD, Chin PC, Li SY. Chromosomal and biochemical screening of mentally retarded school children in Taiwan. Japan J Hum Genet 1991;36:267–274.
21. Allen WP, Taylor H. Mental retardation in South Carolina. VII. Inborn errors of metabolism. Proc Greenwood Genet Ctr 1996;15:76–79.
22. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin North Am 1992;39:929–943.
23. Levy SE, Hyman SL. Pediatric assessment of the child with developmental delay. Pediatr Clin North Am 1993;40:465–477.
24. First LR, Palfrey JS. The infant or young child with developmental delay. N Engl J Med 1994;330:478–483.
25. Curry CJ, Sandhu A, Fritos L, et al. Diagnostic yield of genetic evaluations in developmental delay/mental retardation. Clin Res 1996;44:130A.
26. Martin E, Boesch C, Zuerrer M, et al. MR imaging of brain maturation in normal and developmentally handicapped children. J Comput Assist Tomogr 1990;14:685–692.
27. Squires L, Krishnamoorthy KS, Natowitz MR. Delayed myelination in infants and young children: radiographic and clinical correlates. J Child Neurology 1995;10:100–104.
28. Moeschler J. The use of the CT scan in the medical evaluation of the mentally retarded child. J Pediatr 1981;98:63–65.
29. Lingham S, Kendall BE. Computed tomography in non-specific mental retardation and idiopathic epilepsy. Arch Dis Child 1983;58:628–643.
30. Root S, Carey JC. Brain dysmorphology and developmental disabilities. Proceedings of the Annual DW Smith Workshop on Malformation and Morphogenesis, 1996.
31. Kjos BO, Umansky R, Barkovich AJ. Brain MR imaging in children with developmental retardation of unknown cause: results in 76 cases. Am J Neuroradiol 1990;11:1035–1040.
32. O’Tuama LA, Dickstein DP, Neeper R, et al. Functional brain imaging in neuropsychiatric disorders of childhood. J Child Neurol 1999;14:207–221.
33. Filipek PA, Semrud-Clikeman M, Steingard RJ, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589–601.
34. Prensky AL. An approach to the child with paroxysmal phenomena with emphasis on nonepileptic disorders. In: Dodson WE, Pellock JM, eds. Pediatric epilepsy: diagnosis and therapy. New York: Demos Publications, 1993.
35. Fedio P, Mirsky AF. Selective intellectual deficits in children with temporal lobe or centrencephalic epilepsy. Neuropsychologia 1969;7:287–300.
36. Stores G, Hart J, Piran N. Inattentiveness in school children with epilepsy. Epilepsia 1978;19:169–175.
37. Hernandez MT, Sauerwein HC, Jambaque I, et al. Deficits in executive functions and motor coordination in children with frontal lobe epilepsy. Neuropsychologia 2002;40:384–400.
38. Jambaque I, Lassonde M, Dulac O. The neuropsychology of childhood epilepsy. New York: Plenum, 1999.
40. Coplan J, Gleason JR. Quantifying language development from birth to 3 years using the Early Language Milestone scale. Pediatrics 1990;86:963–971.
41. Frankenburg WK, Dodds J, Archer P, et al. The Denver II: a major revision and restandardization of the Denver Developmental Screening test. Pediatrics 1992;89:91–97.
42. Newborg J, Stock JR, Wnek L. Batelle developmental inventory. Allen, TX: DLM Teaching Resources, 1984.
43. Bayley N. Bayley Scales of Infant Development II. New York: The Psychological Corporation, 1993.
44. Wechsler D. Wechsler preschool and primary scale of intelligence—revised. New York: Psychological Corporation, 1989.
45. Wechsler D. Wechsler intelligence scale for children—III. New York: Psychological Corporation, 1991.
46. Thorndike RL, Hagen EP, Samer JM. Guide for administering and scoring the Stanford-Binet Intelligence Scale, 4th ed. Chicago: Riverside Publishing, 1986.
47. Goodenough FL, Harris DB. Manual of the Goodenough-Harris drawing test. San Antonio: Psychological Corporation, 1963.
48. Kaufman AS, Kaufman NL. Kaufman assessment battery for children. Circle Paines, NM: American Guidance Services, 1983.
49. McCarthy D. Manual of the McCarthy scales of children’s disabilities. San Antonio: Psychological Corporation, 1972.
50. Leiter RG. The Leiter International Performance scale. California: Western Psychological Services, 1969.
51. Achenbach TM. Manual for the Child Behavior Checklist/2–3 and 1992 profile. Burlington, VT: University of Vermont Department of Psychiatry, 1992.
52. Conners CK. Manual for Conners rating scales. North Tonawanda, NY: Multi-Health Systems, 1989.
53. Sparrow SS, Balla DA, Ciccheui DV. Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Services, 1985.
54. Wilkinson GS. The wide range achievement test—revision 3, administration manual. Wilmington, DE: Wide Range, 1993.
55. Woodcock RW, Mather N. Woodcock-Johnson tests of achievement. Allen, TX: DLM Teaching Resources, 1989.
56. Dunn LM, Dunn LM. Peabody picture vocabulary test—revised. Circle Pines, MN: American Guidance Services, 1981.
57. Beery KE. The developmental test of visual-motor integration, 3rd rev. Cleveland: Modern Curriculum Press, 1989.
58. Lyon GR, Fletcher JM, Shaywitz SE. Rethinking learning disabilities. In: Finn CE Jr, Rotherham AJ, Hokanson CR Jr, eds. Rethinking special education for a new century. Washington, DC: Thomas B. Fordham Foundation and the Progressive Policy Institute, 2001:259–287.
59. McQuaid F, Alovisetti M. School psychological services for hearing-impaired children in New York and the New England area. Am Ann Deaf 1981;126:37–43.
60. Davis CJ. Perkins-Binet test of intelligence for the blind. Watertown, MA: Perkins School for the Blind, 1980.
61. Newland TE. The blind learning aptitude test. J Vis Impair Blind 1979;73:134–139.
62. Petersen MC, Kube DA, Palmer FB. Classification of developmental delays. Semin Pediatr Neurol 1998;5:2–14.
63. World Health Organization. The ICD-10: classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
64. American Association on Mental Retardation. Mental retardation: definition, classification, and systems of support, 9th ed. Washington, DC: American Association on Mental Retardation, 1992.
65. American Psychiatric Association. Diagnostic criteria from DSM-IV: diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994:63–66.
66. Hunt E. Will we be smart enough: cognitive changes in the coming workforce. New York: Russell Sage Foundation, 1995.
67. Hunter JE. Cognitive ability, cognitive aptitudes, job knowledge and job performance. J Vocatl Behav 1986;29:340–362.
68. Grossman H. Manual on terminology and classification in mental retardation. Washington, DC: American Association of Mental Retardation, 1973.
69. Reschly JD. Mental retardation: conceptual foundations, definitional criteria, and diagnostic operations. In: Hooper SR, Hynd GH, Mattison RE, eds. Developmental disorders: diagnostic criteria and clinical assessment. Hillsdale, NJ: Lawrence Erlbaum Associates, 1992:23–67.
70. Luckasson R, Borthwick-Duffy S. Mental retardation: definition, classification, and systems of support. Washington, DC: American Association on Mental Retardation, 1992.
71. Mattis S. Neuropsychological assessment of school-aged children. In: Rapin I, Segalowitz SJ, eds. Handbook of neuropsychology, Vol. 6. Child neuropsychology. Amsterdam: Elsevier, 1992:395–415.
72. Cattell RB, Cattell AKS. Handbook for the Culture-Fair Intelligence Test, Scale 2. Champaign, IL: Institute for Personality and Ability Testing, 1973.
73. Raven JC, Court JH, Raven J. Manual for Raven’s Progressive Matrices and Vocabulary Scales. Oxford, UK: Oxford Psychologists’ Press, 1996.
74. Bracken BA, McCallum RS. The Universal Nonverbal Intelligence Test. Chicago, IL, Riverside, 1997.
75. Carey JC, McMahon WM. Neurobehavioral disorders and medical genetics: an overview. In: Goldstein S, Reynolds CR, eds. Handbook of neurodevelopmental and genetic disorders in children. New York: Guilford, 1999:38–60.
76. Jones KL. Smith’s recognizable patterns of human malformation, 5th ed. Philadelphia: Saunders, 1997.
77. Turk J, Hill P. Behavioral phenotypes in dysmorphic syndromes. Clin Dysmorphol 1995;4:105–115.
78. Udwin O. A survey of adults with Williams syndrome and idiopathic infantile hypercalcemia. Dev Med Child Neurol 1990;32:129–136.
79. Gabel S, Tarter RE, Gavaler J, et al. Neuropsychological capacity of Prader-Willi children: general and specific aspects of impairment. Appl Res Ment Retard 1996;7:459–466.
80. Dykens EM, Hodapp RM, Evans DW. Profiles and development of adaptive behavior in children with Down syndrome. Am J Ment Retard 1994;98:580–587.
81. Carlesimo GB, Marotta L, Vicari S. Long-term memory in mental retardation: evidence for a specific impairment in subjects with Down syndrome. Neuropsychologia 1997;35:71–79.
82. Spano M, Mercuri E, Rando T, et al. Motor and perceptual-motor competence in children with Down syndrome: variation in performance with age. Eur J Paediatr Neurol 1999;3:7–13.
83. Rasmussen P, Borjesson O, Wentz E, et al. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol 2001;43:750–754.
84. Carr J. Down’s syndrome: children growing up. Cambridge: Cambridge University Press, 1995.
85. Dennis M, Jacennik B, Barnes MA. The content of narrative discourse in children and adolescents after early-onset hydrocephalus and in normally developing age peers. Brain Lang 1994;46:129–165.
85a. Hessl Y, Rivera S, Reiss AL. The neuroanatomy and neuroendocrinology of Fragile X Syndrome. Mental Retardation and Develop Disabilities Research Reviews 2004;10:17–24.
86. Wisniewski KE, French JH, Fernando S, et al. Fragile-X syndrome: associated neurological abnormality and developmental disabilities. Ann Neurol 1985;18:665–669.
87. Pennington B, Puck M, Robinson A. Language and cognitive development in 47 XXX females followed since birth. Behav Genet 1980;10:31–41.
88. Rovet JF. The psychoeducational characteristics of children with Turner’s syndrome. J Learn Disabil 1993;26:333–341.
89. Lawrence K, Kuntsi J, Coleman M, et al. Face and emotion recognition deficits in Turner syndrome: a possible role for X-linked genes in amygdala development. Neuropsychology 2003;17:39–49.
90. Rovet J, Netley C, Keenan M, et al. The psychoeducational profile of boys with Klinefelter Syndrome. J Learn Disabil 1996;29:180–196.
91. Stefanatos GA, Musikoff H. Specific neurocognitive deficits in Cornelia de Lange syndrome. J Dev Behav Pediatr 1994;15:39–43.
92. Antshel KM, Waisbren SE. Timing is everything: executive functions in children exposed to elevated levels of phenylalanine. Neuropsychology 2003;17:458–468.
93. Diamond A, Prevor M, Callender G, et al. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 1997;62:i–v, 1–208.
94. Channon S, German E, Cassina C, et al. Executive functioning, memory and learning in phenylketonuria. Neuropsychology 2004;18:613–620.
95. Rovet JF. Long-term neuropsychological sequelae of early-treated congenital hypothyroidism. Effects in adolescence. Acta Pediatrica 1999;88:88–95.
96. Antshel KM, Epstein IO, Waisbren SE. Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology 2004;18:658–664.
97. Dykens EM, Rosner BA. Refining behavioral phenotypes: personality-motivation in Williams and Prader-Willi syndromes. Am J Ment Retard 1999;104:158–169.
98. Stojanovik V, Perkins M, Howard S. Williams syndrome and specific language impairment do not support claims for developmental double dissociations and innate modularity. J Neuroling 2004;17:403–424.
99. Pinker S. Words and rules. London: Weidenfeld and Nicolson, 1999.
100. Rutter M, Graham P, Yule W. A neuropsychiatric study in childhood. Clin Dev Med 1970;35/36:1–272.
101. Borthwick-Duffy SA. Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol 1994;62:17–27.
102. Bregman JD. Current developments in the understanding of mental retardation: Part II. Psychopathology. J Am Acad Child Adolesc Psychiatry 1991;30:861–872.
103. Crews WDJ, Bonaventura S, Rowe F. Dual diagnosis: prevalence of psychiatric disorders in a large state residential facility for individuals with mental retardation. Am J Ment Retard 1994;98:724–731.
104. Gillberg C, Persson E, Grufman M, et al. Psychiatric disorders in mildly and severely mentally retarded urban children and adolescents: epidemiological aspects. Br J Psychiatry 1986;149:68–74.
105. Matson JL, Barrett RP, Helsel WJ. Depression in mentally retarded children. Res Dev Disabil 1988;9:39–46.
106. Dawson JE, Matson JL, Cherry KE. An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation. Res Dev Disabil 1998;19:439–448.
107. Gath H, Gumley D. Behavior problems in retarded children with special reference to Down syndrome. Br J Psychiatry 1986;149:156–161.
108. Matson JL, Hamilton M, Duncan D, et al. Characteristics of stereotypic movement disorder and self-injurious behavior assessed with the Diagnostic Assessment for the Severely Handicapped (DASH-II). Res Dev Disabil 1997;18:457–469.
109. Buitelaar JK. Self-injurious behavior in retarded children: clinical phenomena and biological mechanisms. Acta Paedopsychiatrica 1993;56:105–111.
110. Carr KG, Smith CE. Biological setting events for self-injury. MRDD Research Reviews 1995;1.
111. Anderson LT, Ernst M. Self-injury in Lesch-Nyhan disease. J Autism Dev Disord 1994;24:67–81.
112. Matthews WS, Solan A, Barabas G. Cognitive functioning in Lesch-Nyhan syndrome. Dev Med Child Neurol 1995;37:715–722.
113. Whitman BY, Accardo P. Emotional symptoms in Prader-Willi syndrome adolescents. Am J Med Genet 1987;28:897–905.
114. Curfs LM, Fryos JP. Prader-Willi syndrome: a review with special attention to the cognitive and behavioral profile. Birth Defects: Original Article Series 1992;28:99–104.
115. Hagberg B. Rett syndrome: clinical peculiarities and biological mysteries. Acta Paediatrica 1995;84:971–976.
116. Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardiofacial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996;153:1541–1547.
117. Motzkin B, Marion R, Goldberg R, et al. Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 1993;123:406–410.
118. Udwin O, Yule W. Expressive language of children with Williams syndrome. Am J Med Genet 1990;6:108–114.
119. Rossen ML, Samat HB. Why should neurologists be interested in Williams syndrome? [Editorial] Neurology 1998;5:8–9.
120. Marcus LC, Keens GT, Bautista BD, et al. Obstructive sleep apnea in children with Down Syndrome. Pediatrics 1991;88:132–139.
121. Andreou G, Galanopoulou C, Gourgoulianis K, et al. Cognitive status in Down syndrome individuals with sleep disordered breathing deficits (SDB). Brain Cogn 2002;50:145–149.
122. Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J Clin Psychiatry 2003;64:1195–1200.
123. Bassett AS, Hodgkinson K, Chow EWC, et al. 22q11 deletion syndrome in adults with schizophrenia. Am J Med Genet 1998;81:328–337.
124. Gothelf D, Gruber R, Pesburger G, et al. Methylphenidate treatment for attention-deficit/hyperactivity disorder of children and adults with velocardiofacial syndrome: an open label study. J Clin Psychiatry 2003;64:1163–1169.
125. McAuley E, Ross R, Kushner H, et al. Self-esteem and behavior in girls with Turner syndrome. J Dev Behav Ped 1995;16:82–88.
126. Ernst M, Zametkin AJ, Matochik JA, et al. Presynaptic dopaminergic deficits in Lesch-Nyhan disease. N Engl J Med 1996;334:1568–1572.
127. Down syndrome prevalence at birth: United States 1983–1990. MMWR Morb Mortal Wkly Rep 1994;43:617–622.
128. Steele J, Stratford B. The United Kingdom population with Down syndrome: present and future projections. Am J Ment Retard 1995;99:664–682.
129. Str⊘mme P, Valvatne K. Mental retardation in Norway: prevalence and sub-classification in a cohort of 30,037 children born between 1980 and 1985. Acta Paediatr 1998;87:291–296.
130. Hagberg B, Hagberg G, Lewerth A, et al. Mild mental retardation in Swedish school children. II. Etiologic and pathogenetic aspects. Acta Paediatr Scand 1981;70:445–452.
131. Murphy CC, Yeargin-Allsopp M, Decoufle P, et al. The administrative prevalence of mental retardation in 10-year-old children in Atlanta, 1985 through 1987. Am J Public Health 1995;85:319–323.
132. Brett EM, Goodman R. Mental retardation, infantile autism, and related disorders. In: Brett EM, ed. Paediatric neurology. London: Churchill Livingstone, 1997:406–423.
133. McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders, and etiology. Am J Ment Retard 1987;92:243–254.
134. Eyman RK, Grossman HJ, Chaney RH, et al. Survival of profoundly disabled people with severe mental retardation. Am J Dis Child 1993;147:329–336.
135. Plioplys AV, Kasnocka I, Lewis S, et al. Survival rates among children with severe neurological disabilities. South Med J 1998;19:161–172.
136. Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay. Neurology 2003;11:367–380.
137. Gustavson KH, Hagberg B, Hagberg G, et al. Severe mental retardation in a Swedish county. II. Etiologic and pathogenetic aspects of children born 1959–1970. Neuropaediatrie 1977;8:293–304.
138. Nelson KB. What proportion of cerebral palsy is related to birth asphyxia? J Pediatr 1988;112:572–573.
139. Gaffney G, Sellers S, Flavell V, et al. Case-control study of intrapartum care, cerebral palsy, and perinatal death. BMJ 1994;308:743–750.
140. Torfs CP, van den Berg B, Oechsli FW, et al. Prenatal and perinatal factors in the etiology of cerebral palsy. J Pediatr 1990;116:615–619.
141. Watemberg N, Silver S, Harel S, et al. Significance of microcephaly among children with developmental disabilities. J Child Neurol 2002;17:117–122.
142. McAnulty GB, Hicks RE, Kinsbourne M. Personal and familial sinistrality in relation to degree of mental retardation. Brain Cogn 1984;3:349–356.
143. Laxova R, Ridler MAC. An etiologic survey of the severely retarded Hertfordshire children who were born between January 1, 1965 and December 31, 1967. Am J Med Genet 1977;1:75–86.
144. Opitz JM, Kaveggia EG, Laxova R, et al. The diagnosis and prevention of severe mental retardation. Proceedings, lnternational Conference on Preventable Aspects of Genetic Morbidity, 1982, Cairo, ll.
145. Fryns JP, Kleczkowska A, Dereymaeker A, et al. A genetic diagnostic survey in an institutionalized population of 173 severely mentally retarded patients. Clin Genet 1986;30:315–323.
146. McQueen PC, Spence MW, Winsor EJ, et al. Causal origins of major mental handicap in the Canadian mountain provinces. Dev Med Child Neurol 1986;28:697–707.
147. Wellesley D, Hockey A, Stenely F. The aetiology of intellectual disability in westem Australia: a community-based study. Dev Med Child Neurol 1991;33:963–973.
148. Yeargin-Allsopp M, Murphy CC, Cordero JF, et al. Reported biomedical causes and associated medical conditions for mental retardation among 10-year-old children, metropolitan Atlanta, 1985 to 1987. Dev Med Child Neurol 1997;39:142–149.
149. Flint J, Wilkie AO. The genetics of mental retardation. Br Med Bull 1996;52:453–464.
150. Mirrett PL, Bailey DB, Roberts JE, et al. Developmental screening and detection of developmental delays in infants and toddlers with fragile X syndrome. J Dev Behav Ped 2004;25:21–27.
151. Mutch L, Leyland A, McGee A. Patterns of neuropsychological function in a low birth weight population. Dev Med Child Neurol 1993;35:943–956.
152. Breslau N, Paneth NS, Lucia VC. The lingering academic deficits of low birth weight children. Pediatrics 2004;114:1035–1040.
153. Vicari S, Caravale B, Carlesimo GA, et al. Spatial working memory in children at ages 3–4 who were low birth weight preterm infants. Neuropsychology 2004;18:673–678.
154. Hopkins-Golightly T, Raz S, Sander CJ. Influence of slight to moderate risk for birth anoxia on acquisition of cognitive and language function in the pretern infant: a cross-sectional comparison with preterm-birth controls. Neuropsychology 2003;17:3–13.
155. Short EJ, Klein NK, Lewis BA, et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003;112:e359.
156. Casaer P, de Vries L, Marlow N. Prenatal and perinatal risk factors for psychological development. In: M Rutter, P Casaer, eds. Biological risk factors for psychosocial disorders. Cambridge: Cambridge University Press, 1991:139–174.
157. Johnston MV, Trescher WH, Taylor GA. Hypoxic and ischemic nervous system disorders in infants and children. Adv Pediatr 1995;42:1–45.
158. Foulder-Hughes LA, Cooke RW. Motor, cognitive and behavioural disorders in children born very preterm. Dev Med Child Neurol 2003;45:97–103.
159. Williams CE, Gunn AJ, Mallard C, et al. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann Neurol 1992;31:14–21.
160. Taylor HG, Minich N, Bangert B, et al. Long-term neuropsychological outcomes of very low birth weight: associations with early risks for periventricular brain insults. J Int Neuropsychol Soc 2004;10:987–1004.
161. Hunt CE, Corwin MJ, Baird T, et al. Cardiorespiratory events detected by home monitoring and one year neurodevelopmental outcome. J Pediatr 2004;145:465–471.
162. Gottlieb DL, Chase C, Vezina RM, et al. Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr 2004;145:458–464.
163. Dowdeswell HJ, Slater AM, Broomhall J, et al. Visual deficits in children born at less than 32 weeks’ gestation with and without major ocular pathology and cerebral damage. Br J Ophthalmol 1995;79:447–452.
164. Isaacs EB, Lucas A, Chong WK, et al. Hippocampal volume and everyday memory in children of very low birth weight. Pediatr Res 2000;47:713–720.
165. Nosarti C, Al-Asady MH, Frangou S, et al. Adolescents who were born very preterm have decreased brain volumes. Brain 2002;125:1616–1623.
166. Peterson BS, Anderson AW, Ehrenkrantz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939–948.
167. Christ SE, White DA, Brunstrom JE, et al. Inhibitory control following perinatal brain injury. Neuropsychology 2003;17:171–178.
168. Vargha-Khadem F, Isaacs E, van der Werf S, et al. Development of intelligence and memory in children with hemiplegic cerebral palsy. The deleterious consequences of early seizures. Brain 1992;115:315–329.
169. Stiles J. Neural plasticity and cognitive development. Dev Neuropsychol 2000;18:237–272.
170. Breslau N, Chilcoat HD. Psychiatric sequelae of low birth weight at 11 years of age. Biol Psychiatry 2000;47:1005–1011.
171. Max JE, Mathews K, Manes FF, et al. Attention deficit hyperactivity disorder and neurocognitive correlates after childhood stroke. J Int Neuropsychol Soc 2003;9:815–829.
172. Gross-Tsur V, Shalev RS, Badihi N, et al. Efficacy of methylphenidate in patients with cerebral palsy and attention-deficit hyperactivity disorder (ADHD). J Child Neurol 2002;17:863–866.
173. Stratton K, Howe C, Bataglia F. Fetal alcohol syndrome: diagnosis, epidemiology and treatment. Washington, DC: National Academy Press, 1996.
174. Frank DA, Augustyn M, Knight WG, et al. Growth, development and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001;285:1613–1625.
175. Brown JV, Bakeman R, Coles CD, et al. Prenatal cocaine exposure: a comparison of 2-year-old children in parental and non-parental care. Child Dev 2004;1282–1295.
176. Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Devel Med Child Neurol 1994;36:361–369.
177. Bellinger DC. Lead. Pediatrics 2004;113:1016–1022.
178. Schroeder SR, Hawk B, Otto DA, et al. Separating the effects of lead and social factors on IQ. Environ Res 1985;38:144–154.
179. Pocock SJ, Smith M, Baghurst P. Environmental lead and children’s intelligence: a systematic review of the epidemiological literature. BMJ 1994;309:1189.
180. Kaufman AS. Do low levels of lead produce IQ loss in children? A careful examination of the literature. Arch Clin Neuropsychology 2001;6:403–431.
181. Needleman HL, Bellinger D. Studies of lead exposure and the developing central nervous system. A reply to Kaufman. Arch Clin Neuropsychology 2001;6:359–374.
182. Lanphear BP, Dietrich K, Auinger P, et al. Cognitive deficits associated with blood lead concentrations <10 ug/dl in US children and adolescents. Public Health Report 2000;115:521–529.
183. Canfield RL, Henderson CR, Cory–Slechta DA, et al. Intellectual impairment in children with blood lead concentrations below 10 ug per deciliter. N Engl J Med 2003;348:1517–1526.
184. Minder B, Das-Smaal EA, Orlebeke JF. Cognition in children does not suffer from very low lead exposure. J Learn Disabil 1998;31:494–502.
185. Stone BM, Reynolds CR. Can the National Health and Nutrition Examination Survey III (NHANES III) data help resolve the controversy over low lead levels and neuropsychological development in children? Arch Clinical Neuropsychology 2003;18:219–244.
186. O’Carroll RE, Masterton G, Dougall N, et al. The neuropsychiatric sequelae of mercury poisoning. The mad hatter’s disease revisited. Brit J Psychiatry 1995;167:95–98.
187. Warkany J, Hubbard DM. Acrodynia and mercury. J Pediatrics 1953;42:365–386.
188. National Research Council. Toxicological effects of methylmercury. Washington, DC: National Academy Press, 2000.
189. Takeuchi T, Eto K. The pathology of Minimata disease. Japan: Fukuoka Kyushi University Press, 1999.
190. Fukuda Y, Ushijima K, Kitano T, et al. An analysis of subjective complaints in a population living in a methylmercury-polluted area. Environ Res 1999;81:100–107.
191. Bakir F, Rustam H, Tikriti S, et al. Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J 1980;56:1–10.
192. Davis LE, Kornfeld M, Mooney HS, et al. Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann Neurol 1994;35:680–688.
193. Myers GJ, Davidson PW. Prenatal methylmercury exposure and children: neurologic, developmental, and behavioral research. Environ Health Perspect 1998;3:841–847.
194. Grandjean P, Weihe P, White RF, et al. Cognitive performance of children prenatally exposed to “safe” levels of methylmercury. Environ Res A 1998;77:165–172.
195. Weiss B, Clarkson TW, Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002;5:851–854.
196. Jacobson JL, Jacobson SW. Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 2003;143(6):780–788.
197. Vreugdenhil HJ, Lanting CI, Mulder PG, et al. Effects of prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children at school age. J Pediatr 2002;140:48–56.
198. Eskenazi B, Bradman A, Castorina R. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect 1999;107:409–419.
199. Miller RW. Delayed radiation effects in atomic bomb survivors. Science 1969;166:569–574.
200. Dekaban AS. Abnormalities in children exposed to x-radiation and during various stages of gestation: tentative timetable of radiation injury to the human fetus, Part I. J Nucl Med 1968;9:471–477.
201. Uchida IA, Holunga R, Lawler C. Maternal radiation and chromosomal aberrations. Lancet 1968;2:1045–1049.
202. Lozoff B. Nutrition and behavior. Am Psychol 1989;44:231–236.
203. Bronfenbrenner U, McClelland PD, Ceci S, et al. The state of Americans. New York: The Free Press, 1996.
204. Kiely M. The prevalence of mental retardation. Epidemiol Rev 1987;9:194–228.
205. Roeleveld N, Zielhuis GA, Gabreels F. The prevalence of mental retardation: a critical review of recent literature. Dev Med Child Neurol 1997;39:125–132.
206. Patterson CJ, Kupersmidt JB, Vaden NA. Income level, gender, ethnicity, and household composition as predictors of children’s school-based competence. Child Dev 1990;61:485–494.
207. Aber JL, Bennett NG, Conley DC, et al. The effects of poverty on child health and development. Annu Rev Public Health 1997;18:463–483.
208. Ramer JC, Miller G. Overview of mental retardation. In: Miller G, Ramer JC, eds. Static encephalopathies of infancy and childhood. New York: Raven Press, 1992:1–10.
208a. National Institute of Child Health and Human Development Early Child Care Research Network. Duration and developmental timing of children’s cognitive and social development from birth through third grade. Child Develop 2005;76:795–810.
209. Kim-Cohen J, Moffitt TE, Caspi A, et al. Genetic and environmental processes in young children’s resilience and vulnerability to socioeconomic deprivation. Child Dev 2004;75:651–668.
210. Spitz RA. Hospitalism. Psychoanal Stud Child 1945;1:53–74.
211. Gunnar MR. Effects of early deprivation: findings from orphanage-reared infants and children. In: Nelson CA, Luciani M, eds. Handbook of developmental cognitive neuroscience. Cambridge, MA: MIT Press, 2001:617–630.
212. Zeanah CH, Nelson CA, Fox NA, et al. Designing research to study the effects of institutionalization on brain and behavior development: the Bucharest Early Intervention Program. Dev Psychopathol 2003;15:885–907.
213. Chisholm K. A three-year follow-up of attachment and indiscriminate friendliness in children adopted from Romanian orphanages. Child Dev 1998;69:1092–1106.
214. Chugani HT, Behen ME, Muzik O, et al. Local brain functional activity following early deprivation: a study of postinstitutionalized Romanian orphans. Neuroimage 2001;14:290–301.
215. Marshall PJ, Fox NA, BEIP Core Group. A comparison of the electroencephalogram between institutionalized and community children in Romania. J Cogn Neurosci 2004;16:1327–1338.
216. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549–555.
217. Kovacs M, Goldstone D, Iyengar S. Intellectual development and academic performance of children with insulin-dependent diabetes mellitus: a longitudinal study. Dev Psychol 1992;28:676–684.
218. Grantham-McGregor SM, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001;131:649S–668S.
219. Halterman JS, Kaczorowsky JM, Aligne CA, et al. Iron deficiency and cognitive achievement among school-aged children and adolescents in the United States. Pediatrics 107:1381–1386.
220. Aman MG, Kern RA, McGhee DE, et al. Fenfluramine and methylphenidate in children with mental retardation and ADHD: clinical and side effects. J Am Acad Child Adolesc Psychiatry 1993;32:851–859.
221. Campbell M, Cueva JE. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years, Part I. J Am Acad Child Adolesc Psychiatry 1995;34:1124–1132.
222. Herman BH, Hammock MK, Arthur-Smith A, et al. Naltrexone decreases self-injurious behavior. Ann Neurol 1987;22:550–552.
223. Barnes TR. Tardive dyskinesia. BMJ 1988;296:150–151.
224. Swanson JM, Christian DL, Wigal T, et al. Tardive dyskinesia in a developmentally disabled population: manifestation during the initial stage of a minimal effective-dose program. Exp Clin Psychopharmacol 1996;4:1–6.
225. Ottenbacher K, Petersen P. The efficacy of early intervention programs for children with organic handicaps. Eval Prog Plan 1985;8:135.
226. Dodrill CB. Neuropsychology. In: Laidlaw J, Richens A, Chadwick D, eds. A textbook of epilepsy, 4th ed. New York: Churchill Livingstone, 1993:459–473.
227. Mayeux R, Brandt J, Rosen J, et al. Interictal and language impairment in temporal lobe epilepsy. Neurology 1980;30:120–125.
228. Caplan R, Siddarth P, Gurbani S, et al. Psychopathology and pediatric complex partial seizures: seizure-related, cognitive and linguistic variables. Epilepsia 2004;45:1273–1281.
229. Rapin I, Katzman R. Neurobiology of autism. Ann Neurol 1998;43:7–14.
230. Wing L. The autistic spectrum. Lancet 1997;350:1761–1766.
231. Pervasive developmental disorders. In: Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994:65–78.
232. Folstein SE, Rutter ML. Infantile autism: a genetic study of 21 twin pairs. J Child Psychol Psychiatry 1977;18:297–321.
232a. Bolton PF, Murphy M, Macdonald H, et al. Obstetric complications in autism. Consequences or causes of the condition. J Aner Head Child Adoles Psychiat 1997;36:272–281.
233. Gillberg C, Gillberg IC. Infantile autism: a total population study of reduced optimality in the pre-, peri-, and neonatal period. J Autism Dev Disord 1983;13:153–166.
234. Tsai LY, Stewart MA. Etiological implication of maternal age and birth order in infantile autism. J Autism Dev Disord 1983;13:57–65.
235. Bryson SE, Smith IM, Eastwood D. Obstetrical suboptimality in autistic children. J Am Acad Child Adolesc Psychiatry 1988;27:418–422.
236. Mason-Brothers A, Ritvo ER, Pingree C, et al. The UCLA–University of Utah epidemiologic survey of autism: prenatal, perinatal, and postnatal factors. Pediatrics 1990;86:514–519.
237. Ritvo ER, Jorde LB, Mason-Brothers A, et al. The UCLA–University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146:1032–1036.
238. Wolff S, Narayan S, Moyes B. Personality characteristics of parents of autistic children: a controlled study. J Child Psychol Psychiatry 1988;29:143–153.
239. Steffenberg S, Gillberg C. Autism and autistic-like conditions in Swedish rural and urban areas: a population study. Br J Psychiatry 1986;149:81–87.
240. Bolton P, Macdonald H, Pickles A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877–900.
241. Ritvo ER, Freeman BJ, Mason-Brothers A, et al. Concordance for the syndrome of autism in 40 pairs of afflicted twins. Am J Psychiatry 1985;142:74–77.
242. Steffenberg S, Gillberg C, Holmgren L. A twin study of autism in Denmark, Finland, Iceland, Norway, and Sweden. J Child Psychol Psychiatry 1989;30:405–416.
243. Piven J, Gayle J, Chase GA, et al. A family history study of neuropsychiatric disorders in the adult siblings of autistic individuals. J Am Acad Child Adolesc Psychiatry 1990;29:177–183.
244. Gillberg C, Gillberg IC, Steffenburg S. Siblings and parents of children with autism: a controlled population-based study. Dev Med Child Neurol 1992;34:389–398.
245. Philippe A, Martinez M, Guilloud-Bataille M, et al. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum Mol Genet 1999;8:805–812.
246. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996;38:191–202.
247. Ritvo ER, Mason-Brothers A, Freeman BJ, et al. The UCLA–University of Utah epidemiologic survey of autism: the etiologic role of rare diseases. Am J Psychiatry 1990;147:1614–1621.
248. Schroer RJ, Phelan MC, Michaelis RC, et al. Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 1998;76:327–333.
249. Reiss AL, Feinstein C, Rosenbaum KN, et al. Autism associated with Williams syndrome. J Pediatrics 1985;106:247–249.
250. Gillberg C, Rasmussen P. Brief report: four case histories and a literature review of Williams syndrome and autistic behavior. J Autism Dev Disord 1994;24:381–393.
251. Bundey S, Hardy C, Vickers S, et al. Duplication of the 15q11-13 region in a patient with autism, epilepsy, and ataxia. Dev Med Child Neurol 1994;36:736–742.
252. Gurrieri F, Battaglia A, Torrisi L, et al. Pervasive developmental disorder and epilepsy due to maternally derived duplication of 15q11-q13. Neurology 1999;52:1694–1697.
253. Graf WD, Marin-Garcia J, Gao HG, et al. Autistic regression associated with a mutation in the mitochondrial tRNAlys gene (G8363A). Ann Neurol 1998;44:578.
254. Rogers SJ, Newhart-Larson S. Characteristics of infantile autism in five children with Leber’s congenital amaurosis. Dev Med Child Neurol 1989;31:598–608.
255. McKusick VA. Mendelian inheritance in man: catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes. Baltimore: The Johns Hopkins University Press, 1992:1893–1894.
256. Reiss AL, Freund L. The behavioral phenotype of fragile X syndrome: DSM-111-R autistic behavior in males. Am J Med Genet 1992;43:35–46.
257. Singh VK, Fudenberg HH, Emerson D, et al. Immunodiagnosis and immunotherapy in autistic children. Ann NY Acad Sci 1988;540:602–604.
258. Zimmerman A, Frye V, Potter N. Immunological aspects of autism. Int Pediatr 1993;8:199–204.
259. Todd RD, Hickok JM, Anderson GM, et al. Antibrain antibodies in infantile autism. Biol Psychiatry 1988;23:644–647.
260. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637–641.
261. Chess S. Autism in children with congenital rubella. J Autism Child Schizophr 1971;1:33–47.
262. Ivarsson SA, Bjerre I, Vegfors P, et al. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990;21:102–103.
263. Lowe TL, Tanaka K, Seashore MR, et al. Detection of phenylketonuria in autistic and psychotic children. JAMA 1980;243:126–128.
264. Rutter M, Bartak L. Causes of infantile autism: some considerations from recent research. J Autism Child Schizophr 1971;1:20–32.
265. Kotsopoulos S, Kutty KM. Histidinemia and infantile autism. J Autism Dev Disord 1979;9:55–60.
266. Gillberg I, Gillberg C, Kopp S. Hypothyroidism and autism spectrum disorders. J Child Psychol Psychiatry 1992;33:531–542.
267. D’Eufemia P, Celli M, Finocchiaro R, et al. Abnormal intestinal permeability in children with autism. Acta Pediatr 1996;85:1076–1079.
268. Rapin I. Autism in search of a home in the brain. Neurology 1999;52:902–904.
269. Courchesne E, Yeung-Courchesne R, Press GA, et al. Hypoplasia of cerebellar lobules Vl and Vll in infantile autism. N Engl J Med 1988;318:1349–1354.
270. Murakami JW, Courchesne E, Press GA, et al. Reduced cerebellar hemisphere size and its relationship to vermal hypoplasia in autism. Arch Neurol 1989;46:689–694.
271. Holttum JR, Minshew NJ, Sanders RS, et al. Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry 1992;32:1091–1101.
272. Kleiman MD, Neff S, Rosman NP. The brain in infantile autism: are posterior fossa structures abnormal? Neurology 1992;42:753–760.
273. Garber HJ, Ritvo ER. Magnetic resonance imaging of the posterior fossa in autistic adults. Am J Psychiatry 1992;149:245–247.
274. Piven J, Saliba K, Bailey J, et al. An MRI study of autism: the cerebellum revisited. Neurology 1997;49:546–551.
275. Kemper TL, Bauman M. Neuropathology of infantile autism. J Neuropathol Exp Neurol 1998;57:645–652.
276. Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology 1999;52:917–922.
277. Bailey A, Luthert P, Dean A. A clinicopathological study of autism. Brain 1998;121:889–905.
278. Piven J, Berthier ML, Starkstein SE, et al. Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism. Am J Psychiatry 1990;147:734–739.
279. Bauman M, Kemper T. Neuroanatomic observations of the brain in autism. In: Bauman M, Kemper T, eds. The neurobiology of autism. Baltimore: The Johns Hopkins University Press, 1994:119–145.
280. Horwitz B, Rumsey JM, Grady CL, et al. The cerebral metabolic landscape in autism. Intercorrelations of regional glucose utilization. Arch Neurol 1988;45:749–755.
281. Jacobson R, Le Couteur A, Howlin P, et al. Selective subcortical abnormalities in autism. Psychol Med 1988;18:39–48.
282. Prior MR, Tress B, Hoffman WL, et al. Computed tomographic study of children with classic autism. Arch Neurol 1984;41.
283. Creasey H, Rumsey JM, Schwartz M, et al. Brain morphometry in autistic men as measured by volumetric computed tomography. Arch Neurol 1986;43:669–672.
284. Fombonne E, Roge B, Claverie J, et al. Microcephaly and macrocephaly in autism. J Autism Dev Disord 1999;29:113–119.
285. Minshew NJ. Indices of neural function in autism: clinical and biologic implications. Pediatrics 1991;87:774–780.
286. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children. II. Epilepsy. Pediatrics 1991;88:1219–1225.
287. Bauman ML, Kemper TL. Abnormal cerebellar circuitry in autism? Neurology 1989;39:186.
288. Gaffney GR, Kuperman S, Tsai LY, et al. Morphological evidence of brain stem involvement in infantile autism. Biol Psychiatry 1988;24:578–586.
289. Hsu M, Yeung-Courchesne R, Courchesne E, et al. Absence of magnetic resonance imaging evidence of pontine abnormalities in infantile autism. Arch Neurol 1991;48:1160–1163.
290. Anderson GM, Freedman DX, Cohen DJ, et al. Whole blood serotonin in autistic and normal subjects. J Child Psychol Psychiatry 1987;28:885–900.
291. McDougle CJ, Naylor ST, Goodman WK, et al. Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry 1993;33:547–550.
292. Cook EH, Leventhal BL. The serotonin system in autism. Curr Opin Pediatr 1996;8:348–354.
293. Chugani DC, Muzik O, Rothermel R, et al. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997;42:666–669.
294. Gillberg C, Svennerholm L. CSF monoamines in autistic syndromes and other pervasive developmental disorders of early childhood. Br J Psychiatry 1987;151:89–94.
295. Ross DL, Klykylo WM, Anderson GM. Cerebrospinal fluid indoleamine and monoamine effects in fenfluramine treatment of autism. Ann Neurol 1985;18:394.
296. Narayan M, Srinath S, Anderson GM, et al. Cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid in autism. Biol Psychiatry 1993;33:630–635.
297. Lake CR, Ziegler MG, Murphy DL. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 1977;34:553–556.
298. Leventhal BL, Cook EH Jr, Morford M, et al. Relationships of whole blood serotonin and plasma norepinephrine within families of autistic children. J Autism Dev Disord 1990;20:499–511.
299. Minderaa RB, Anderson GM, Volkmar FR, et al. Noradrenergic and adrenergic functioning in autism. Biol Psychiatry 1994;36:237–241.
300. Kalat JW. Speculation on similarities between autism and opiate addiction. J Autism Child Schizophr 1978;8:477–479.
301. Ross DL, Klykylo WM, Hitzemann R. Reduction of elevated CSF beta-endorphin by fenfluramine in infantile autism. Pediatr Neurol 1987;3:83–86.
302. Coid J, Allolio B, Rees LH. Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet 1983;2:545–546.
303. Herman B. A possible role of proopiomelanocortin peptides in self-injurious behavior. Prog Neuropsychopharmacol Biol Psychiatry 1990;14[Suppl]:S109–139.
304. Gillberg C. Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 1995;37:239–245.
305. Kanner L. Autistic disturbances of affective contact. Nervous Child 1943;2:217–250.
306. Bishop DMV. Autism, Asperger’s syndrome and semantic-pragmatic disorder: where are the boundaries? Br J Disord Commun 1989;24:107–121.
307. Bolton P, Macdonald H, Pickels A, et al. A case-control family history study of autism. J Child Psychol Psychiatry 1994;35:877–900.
308. Bailey A, LeCouteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
309. Kurita H. Infantile autism with speech loss before the age of 30 months. J Amer Acad Child Psychiatry 1985;24:191–196.
310. Lord C, Shulman C, DiLavore P. Regression and word loss in autistic spectrum disorders. J Child Psychol Psychiatry 2004;45:936–955.
311. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003;25:377–382.
312. Tuchman RF, Rapin I. Regression in pervasive developmental disorders: seizures and epileptiform encephalogram correlates. Pediatrics 1997;99:560–566.
313. Rogers SJ. Developmental regression in autism spectrum disorders. Ment Retard Dev Disabil Res Rev 2004;10:139–143.
314. Rice D, Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000;108[Suppl 3]:511–533.
315. Baron-Cohen S, Cox A, Baird G, et al. Psychological markers in the detection of autism in infancy in a large population. Br J Psychiatry 1996;168:158–163.
316. Osterling J, Dawson G. Early recognition of children with autism: a study of first birthday home video tapes. J Autism Dev Disord 1994;24:247–257.
317. Miles JH, Hillman RE. Value of a clinical morphology examination in autism. Am J Med Genet 2000;91:245–253.
318. Bauman ML. Motor dysfunction in autism. In: Joseph AB, Young RR, eds. Movement disorders in neurology and neuropsychiatry. Boston: Blackwell Science, 1992:658–661.
319. Lovaas O, Koegel R, Schreibman L. Stimulus overselectivity in autism: a review of research. Psychol Bull 1979;86:1236–1254.
320. Smith IM, Bryson SE. Imitation in autism. Cogn Neuropsychol 1998;15:747–771.
321. Tuchman RF, Rapin I, Shinnar S. Autistic and dysphasic children: clinical characteristics. Pediatrics 1991;88:1211–1218.
322. Rapin I, Dunn M. Language disorders in children with autism. Semin Pediatr Neurol 1997;4:86–92.
323. Tirosh E, Canby J. Autism with hyperlexia: a distinct syndrome? Am J Ment Retard 1993;98:84–92.
324. Grigorenko EL, Klin A, Pauls DL, et al. A descriptive study of hyperlexia in a clinically referred sample of children with developmental delays. J Autism Dev Disord 2003;32:3–12.
325. Liss C, Saulnier C, Fine D, et al. Sensory and attention abnormalities in autistic spectrum disorders. Autism, in press.
326. Kinsbourne M. Overfocusing: an apparent subtype of attention-deficit hyperactivity disorder. In: Amir N, Rapin I, Branski D, eds. Pediatric neurology: behavior and cognition of the child with brain dysfunction. Basel: Karger, 1991:18–35.
326a. Mann TA, Walker P. Autism and a deficit in broadening the spread of visual attention. J Child Psychol Psychiatry 2003;44:274–284.
326b. Frith U. Autism explaing the enigma. Oxford, Blackwell, 1989.
326c. Hermelin B, O’Connor N. Idiot savant calendrical calculators: rules and regularities. Psychol Med 1986;16:885–893.
326d. Happe FGE. Central coherence and theory of mind in autism: reading homographs in context. Brit J Develop Psychol 1997;15:1–12.
327. Boucher J, Lewis V. Unfamiliar face recognition in relatively able autistic children. J Child Psychol Psychiatry 1992;33:843–859.
328. Dawson G, Meltzoff AN, Osterling J, et al. Children with autism fail to orient to naturally occurring social stimuli. J Autism Dev Disord 1998;28:479–485.
329. Volkmar FR. The disintegrative disorders: childhood disintegrative disorder and Rett’s disorder. In: Volkmar FR, ed. Psychoses and pervasive developmental disorders in childhood and adolescence. Washington, DC: American Psychiatric Press, 1996:223–248.
330. Wing L. Asperger’s syndrome: a clinical account. Psych Rev 1981;11:115–129.
331. Baltaxe CAM, Simmons JQI. A comparison of language issues in high-functioning autism and related disorders with onset in childhood and adolescence. In: Schopler E, Mesibov GB, eds. High-functioning individuals with autism. New York: Plenum Publishing, 1991:201–225.
332. Rumsey JM, Hamburger SD. Neuropsychological findings in high-functioning men with infantile autism, residual state. J Clin Exp Neuropsychol 1988;10:201–222.
332a. Lord C, Rutter M, LeCouteur A. Interviw—Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 1994;24:659–685.
332b. Lord C, Risi S, Lambrecht L, et al. The Autism Diagnostic observation schedule—generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205–223.
333. Charman T, Baron-Cohen I, Baird G, et al. Commentary: the modified checklist for autism in toddlers. J Autism Dev Disord 2001;31:145–148.
334. Rogers SJ, DiLalla DL. Age of symptom onset in young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1990;29:863–872.
335. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
336. Wing L. The definition and prevalence of autism: a review. Eur Child Adol Psychiatry 1993;2:61–74.
337. Shapiro T, Hertzig ME. Social deviance in autism: a central integrative failure as a model for social nonengagement. Psychiatr Clin North Am 1991;14:19–32.
338. Ehlers S, Gillberg C. The epidemiology of Asperger’s syndrome: a total population study. J Child Psychol Psychiatry 1993;34:1327–1350.
339. Honda H, Shimizu Y, Misumi K, et al. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry 1996;169:228–235.
340. Webb EVJ, Lobo S, Hervas A, et al. The changing prevalence of autistic disorder in a Welsh health district. Dev Med Child Neurol 1997;39:150–152.
341. Bertrand J, Mars A, Boyle C, et al. Prevalence of autism in a United States population: the Brick township, New Jersey, investigation. Pediatrics 2001;108:1155–1161.
342. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093–3099.
343. Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev 2002;8:151–161.
344. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003;33:365–382.
345. Yeargin-Allsopp M, Rice C, Karapurkar T, et al. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49–55.
346. Croen LA, Grether JK, Selvin S. Descriptive epidemiology of autism in a California population: who is at risk? J Autism Dev Disord 2002;32:217–224.
347. Blaxill MF. What’s going on? The question of time trends in autism. Public Health Rep 2004;119:536–551.
348. Mandell DS, Thompson WW, Weintraub ES, et al. Trends in diagnosis rates for autism and ADHD at hospital discharge in the context of other psychiatric diagnoses. Psychiatr Serv 2005;56:56–62.
349. Bettelheim B. The empty fortress: infantile autism and the birth of the self. New York: Free Press, 1967.
350. Baird TD, Augus TGJ. Familial heterogeneity in infantile autism. J Autism Dev Disord 1985;15:315–321.
351. Ritvo ER, Jorde LB, Mason-Brothers A, et al. The UCLA–University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 1989;146:1032–1036.
352. Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63–77.
353. Wassink TH, Piven J. The molecular genetics of autism. Curr Psychiatry Rep 2000;2:170–175.
354. Carper RA, Moses P, Tigue ZD, et al. Cerebral lobes in autism: early hyperplasia and abnormal age effects. NeuroImage 2002;1038–1051.
354a. Aylward EH, Minshew NJ, Field K, et al. Effects of age on brain volume and head circumference in autism. Neurol 2002;59:175–183.
355. Herbert MR, Ziegler DA, Makris N, et al. Localization of white matter volume increase in autism and developmental language disorder. Annals Neurol 2004;55:530–540.
356. Lainhart JE. Increased rate of head growth during infancy in autism. JAMA 2003;290:393–394.
357. Rapin I. Autism in search of a home in the brain. Neurology 1999;52:902–904.
358.
359. DeLong GR. Autism: new data suggest a new hypothesis. Neurology 1999;52:911–916.
360. Minshew NJ, Luna B, Sweeney JA. Oculomotor evidence for neocortical systems but not cerebellar dysfunction in autism. Neurology 1999;52:917–922.
361. Courchesne E, Townsend J, Saitoh O. The brain in infantile autism: posterior fossa structures are abnormal. Neurology 1994;44:214–223.
362. Bailey A, Luthert P, Dean A. A clinicopathological study of autism. Brain 1998;121:889–905.
363. Palmen SJMC, Engeland H van, Hop PR, et al. Neuropathological findings in autism. Brain 2004;127:2572–2583.
364. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2003;25:377–382.
365. Damasio AR, Maurer RG. A neurological model for childhood autism. Arch Neurol 1978;35:777–786.
366. Bishop DVM. Autism, executive functions and theory of mind: a neurological perspective. J Child Psychol Psychiatry 1993;34:279–293.
367. Bachevalier J. An animal model for childhood autism: memory loss and socioemotional disturbances following damage to the limbic system in monkeys. In: Tammiga CA, Schultz SC, eds. Advances in neuropsychiatry and psychopharmacology, Vol. 1. Schizophrenia Research. New York: Raven Press, 1991:129–140.
368. Kinsbourne M. Cerebral-brain stem relations in infantile autism. In: Schopler E, Mesibov GB, eds. Neurobiological issues in autism. New York: Plenum, 1987:107–125.
369. Casanova MF, Buxhoeveden DP, Switala AE, et al. Minicolumnar pathology in autism. Neurology 2002;58:428–432.
370. Belmonte MK, Yurgelun-Todd DA. Functional anatomy of impaired selective attention and compensatory processing in autism. Brain Res Cogn Brain Res 2003;17:651–664.
371. Just MA, Cherkassky VL, Keller TA, et al. Cortical activation and synchronization during sentence completion in high-functioning autism: evidence of underconnectivity. Brain 2004;127:1811–1821.
372. Hagberg B, Aicardi J, Dias K, et al. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett syndrome. Report of 35 cases. Ann Neurol 1983;14:471–479.
373. Bailey DB, Mesibov GB, Hatton DD, et al. Autistic behavior in young boys with fragile X syndrome. J Autism Dev Disord 1998;28:499–508.
374. Splawski, I, Timothy KW, Sharpe LM, et al. CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004;119:19–31.
375. Stromland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Devel Med Child Neurol 1994;36:351–356.
376. Rodier SJ. The early origins of autism. Sci Amer 2000;282:56–63.
377. Volkmar FR, Douglas NS. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990;29:127–129.
378. Wong V. Epilepsy in children with autistic spectrum disorder. J Child Neurol 1993;8:316–322.
379. Lord C, Mulloy C, Wendelboe M, et al. Pre- and perinatal factors in high-functioning females and males with autism. J Autism Dev Disord 1991;21:197–209.
380. Dunn HG, ed. Sequelae of low-birth-weight: the Vancouver Study. Clin Dev Med 1986;95/96:68–96.
381. DeLong GR, Bean SC, Brown FR. Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 1981;38:191–194.
382. Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for childhood autism. Dev Med Child Neurol 1991;920–924.
383. Oades RD, Slusarek M, Velling S, et al. Serotonin platelet-transporter measures in childhood attention-deficit/hyperactivity disorder (ADHD): clinical versus experimental measures of impulsivity. World J Biol Psychiatry 2002;3:96–100.
384. Korvatska E, Van der Water J, Anders TF, et al. Genetic and immunological considerations in autism. Neurobiol Dis 2002;9:107–125.
385. Jyonouchi H, Sun SN, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorder and developmental regression. J Neuroimmunol 2001;120:170–179.
386. Warren RP, Margaretten NC, Pace NC, et al. Immune abnormalities in patients with autism. J Autism Dev Disorders 1986;16:189–197.
387. Zimmerman A, Frye V, Potter N. Immunological aspects of autism. Int Pediatr 1993;8:199–204.
388. Todd RD, Hickok JM, Anderson GM, et al. Antibrain antibodies in infantile autism. Biol Psychiatry 1988;23:644–647.
389. Sweeten TL, Bowyer SL, Posey DJ, et al. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003;112:e420.
390. Silva SC, Correia C, Fesel C, et al. Autoantibody repertoires to brain tissue in autism nuclear families. J Neuroimmunology 2004;152:176–182.
391. Vojdani A, O’Bryan T, Green JA, et al. Immune response to dietary proteins, gliadin, and cerebellar peptides in children with autism. Nutr Neurosci 2004;7:151–161.
392. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67–81.
393. Gillberg C, Coleman M. Autism and medical disorders: a review of the literature. Dev Med Child Neurol 1996;38:191–202.
394. Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in neurobiological esearch. J Psychiatry Neurosci 1999;24:103–115.
395. Nanson JL. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 1992;16:558–565.
396. Davis E, Fennoy I, Laraque D, et al. Autism and developmental disabilities in children with perinatal cocaine exposure. J Natl Med Assoc 1992;84:315–319.
397. Stromland K, Nordin V, Miller M, et al. Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 1994;36:351–356.
398. Christianson AL, Chesler N, Kromberg JGR. Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs. Dev Med Child Neurol 1994;36:357–369.
399. Ward AJ. A comparison and analysis of the presence of family problems during pregnancy of mothers of “autistic” children and mothers of normal children. Child Psychiatry Hum Dev 1990;20:279–288.
400. Sweeten TL, Posey DJ, McDougle CJ. Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 2004;34:583–586.
401. Geuze E, Vermetten E, Bremner JD. MR-based in vivo hippocampal volumetrics: 2. Findings in neuropsychiatric disorders. Mol Psychiatry 2005;10:160–184.
402. Gillberg IC. Autistic syndrome with onset at age 31 years: herpes encephalitis as a possible model for chidhood autism. Dev Med Child Neurol 1991;33:912–929.
403. Ghaziuddin M, Al-Khouri I, Ghaziuddin N. Autistic syndrome following herpes encephalitis. Eur J Child Adolesc Psychiatry 2002;11:142–146.
404. Desmond MM, Wilson GS, Melnick JL, et al. Congenital rubella encephalitis. Course and early sequelae. J Pediatr 1967;71:311–331.
405. Hornig M, Lipkin WI. Infectious and immune factors in the pathogenesis of neurodevelopmental disorders: epidemiology, hypotheses and animal models. Ment Retard Devel Disabil Res Rev 2001;7:200–210.
405a. Barak Y, Kimhi R, Stein D, et al. Child Psychiatry Human Dev 1999;29:245–251.
406. Ciaranello AL, Ciaranello RD. The neurobiology of infantile autism. Ann Rev Neurosci 1995;18:101–128.
407. Fatemi Sh, Earle J, Kamodia R, et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002;22:25–33.
408. Shi L, Fatemi SH, Sidwell RW, et al. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003;23:297–302.
409. Pfeiffer ZRF, Quigley EMM. Neurogastroenterology. Semin Neurol 1996;16.
410. Horvath K, Papadimitriou JC, Rabsztyn A. Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 1999;135:559–563.
411. Torrente F, Ashwood P, Day R, et al. Small intestine enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 2002;7:375–382,334.
412. Ashwood P, Anthony A, Torrente F, et al. Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 2004;24:664–673.
413. Montgomery SM, Morris DL, Pounder RE, et al. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999;116:796–803.
414. Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental? Lancet 1998;351:611–612.
415. Lee JW, Melgaard B, Clements CJ, et al. Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998;351:905.
416. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 1999;353:2026–2029.
417. Uhlmann V, Martin CM, Shiels O, et al. Potential viral; pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 2002;55:84–90.
418. Bradstreet JJ, El Dahr J, Anthony A, et al. Detection of measles virus genomic RNA in cerebrospinal fluid of children with regressive autism: a report of three cases. J Am Phys Surg 2004;9:38–45.
419. Prior M, Eisenmajer R, Leekam S, et al. Are there subgroups within the autistic spectrum? A cluster analysis of a group of children with autistic spectrum disorders. J Child Psychol Psychiatry 1998;39:893–902.
420. Heller T. Dementia infantilis. Zeitschrift für die Erforschung und Behandlung des Jugendlichen Schwachsinns 1908;2:141–165.
421. Fombonne E. Prevalence of childhood disintegrative disorder. Autism 2002;6:149–157.
422. Eggers C, Bunk D, Krause D. Schizophrenia with onset before age of eleven: clinical characteristics of onset and course. J Autism Dev Disord 2000;30:29–40.
423. Russell AT. The clinical presentation of childhood-onset schizophrenia. Schizophr Bull 1994;20:631–646.
424. McLellan JM, Werry J. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:616–635.
425. Jones P, Rodgers B, Murray R, et al. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398–1402.
426. Walker E, Lewine RJ. Prediction of adult-onset schizophrenia from childhood home movies of the patients. Am J Psychiatry 1990;147:1052–1056.
426a. Niemi L, Surisuari J, Tuulio-Henrikson A, et al. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophrenia Res 2003;60:239–258.
427. Walker E, Baum K, Diforio D. Developmental changes in the behavioral expression of vulnerability for schizophrenia. In: Lenzenweger M, Dworkin R, eds. Origins and development of schizophrenia. Washington, DC: American Psychological Association Press, 1998:469–492.
428. Kolvin I, Fundudis T. Elective mute children: psychological development and background factors. J Child Psychol Psychiatry 1981;22:219–232.
429. Bartak L, Rutter M, Cox A. A comparative study of infantile autism and specific developmental receptive language disorder. I. The children. Br J Psychiatry 1975;126:127–145.
430. Plioplys AV. Autism: electroencephalogram abnormalities and clinical improvement with valproic acid. Arch Pediatr Adolesc Med 1994;148:220–222.
431. Stefanatos GA, Grover W, Geller E. Case study: corticosteroid treatment of language regession in pervasive developmental disorder. J Am Acad Child Adolesc Psychiatry 1995;34:1107–1111.
432. Lewine JD, Andrews R, Chez M, et al. Magnetoencephalographic patterns of epileptic form activity in children with regressive autism spectrum disorders. Pediatrics 1999;104:405–418.
433. Howlin P. Practitioner review: psychological and educational treatments for autism. J Child Psychol Psychiatry 1998;39:307–322.
434. Kjelgaard MM, Tager-Flusberg H. An investigation of language impairment in autism: implications for genetic subgroups. Lang Cogn Proc 2001;16:287–308.
435. Rapin I, Dunn M. Update on the language disorders of individuals on the autistic spectrum. Brain Dev 2003;25:166–172.
436. Herbert M, et al. MRI structural imaging of autism and developmental language disorder: a review and commentary. In: Sinha K, Chandra P, eds. Advances in clinical neuroscience, 2003.
437. Herbert MR, Ziegler DA, Deutsch C, et al. Brain asymmetries in autism and developmental language disorder: a nested whole-brain analysis. Brain 2005;128:213–226.
438. Folstein SE, Mankoski RE. Chromosome 7q: where autism meets language disorder? Am J Hum Genet 2000;67:278–281.
439. Warburton P, Baird G, Chen W, et al. Support for linkage of autism and specific language impairment to 7q3 from two chromosome rearrangements involving band 7q31. Am J Med Genet 2000;396:228–234.
440. Wassink TH, Piven J. The molecular genetics of autism. Curr Psychiatry Rep 2000;2:170–175.
441. Bradford Y, Haines J, Hutcheson H, et al. Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet 2001;105:539–547.
442. Alarcon M, Cantor RM, Liu J, et al. Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet 2002;70:60–71.
443. DeLong GR, Teague LA, McSwain-Kamran M. Effects of fluoxetine treatment in young children with idiopathic autism: a case series. Dev Med Child Neurol 1998;40:551–562.
444. Nicholson R, Awad G, Sloman L. An open trial of risperidone in young autistic children. J Am Acad Child Adolesc Psychiatry 1998;37:372–376.
445. Shea S, Turgay A, Carroll A, et al. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 2004;114:e634–e641.
445a. Barnard L, Young AH, Pearson J, et al. A systematic review of the use of atypical antipsychotics in autism. J Psychopharm 2002;16:93–101.
446. Fankhauser MP, Karumanchi VC, German ML, et al. A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry 1992;53:77–82.
447. Volkmar FR. Pharmacological interventions in autism: theoretical and practical issues. J Clin Child Psychol 2001;30:80–7.
448. Birmaher B, Quintana H, Greenhill L. Methylphenidate for the treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry 1988;27:248–251.
449. Raiten DJ, Massaro T. Perspectives on the nutritional ecology of autistic children. J Autism Dev Disord 1986;16:133–144.
450. Pfeiffer SI, Norton J, Nelson L, et al. Efficacy of vitamin B6 and magnesium in the treatment of autism: a methodology review and summary of outcomes. J Autism Dev Disord 1995;25:481–494.
451. Reichelt PM, Scott H, Ekrem J. Gluten, milk proteins and autism: the result of dietary intervention on behaviour and peptide secretion. J Appl Nutr 1990;42:1–11.
452. Knivsberg AM, Reichelt KL, Nodland M. Reports on dietary intervention in autistic disorders. Nutr Neurosci 2001;4:25–37.
453. Lightdale JR, Hayer C, Duer A, et al. Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded open label study. Pediatrics 2001;108:E90.
454. Sandler RH, Finegold SM, Bolte ER, et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000;15:429–435.
455. Klin A, Jones W, Schultz R, et al. The enactive mind, or from actions to cognition: lessons from autism. Philos Trans R Soc Lond B Biol Sci 2003;358:345–360.
456. Ozonoff S, Miller NJ. Teaching theory of mind: a new approach to social skills training for individuals with autism. J Autism Dev Disord 1995;25:415–433.
457. McEachin J, Smith T, Lovaas O. Long-term outcome for children with autism who received early intensive behavioral treatment. Am J Ment Retard 1993;4:359–372.
458. Schopler EA. Statewide program for the treatment and education of autistic and related communication handicapped children (TEACCH). In: Volkmar F, ed. Child and adolescent psychiatric clinics of North America: psychoses and pervasive developmental disorders. Philadelphia: WB Saunders, 1994:91–103.
459. Lord C. Facilitating social inclusion. In: Schopler E, Mesibov GB, eds. Learning and cognition in autism. New York: Plenum, 1995:221–239.
460. Mesibov GB. A comprehensive program for serving people with autism and their families: the TEACCH model. In: Matson JL, ed. Autism in children and adults: etiology, assessment and intervention. Belmont, CA: Brooks-Cole, 1995:85–97.
461. Strain PS, Cordisco L. LEAP preschool. In: Harris S, Handelman J, eds. Preschool education programs for children with autism. Austin, TX: PRO-ED, 1994:225–252.
462. Harris SL. Educational strategies in autism. In: Schopler E, Mesibov GB, eds. Learning and cognition in autism. New York: Plenum, 1995:293–309.
463. Rogers S, Lewis H. An effective day treatment model for young children with pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 1989;28:207–214.
464. Gresham FM, Beebe-Frankenberger ME, MacMillan DL. A selective review of treatments for children with autism: description and methodological considerations. School Psycholog Rev 1999;28:559–575.
465. Howlin P. Children with autism and Asperger syndrome: a guide for practitioners and carers. Chichester: John Wiley & Sons, 1998.
466. Matson JL, Benavidez DA, Compton LS, et al. Behavioral treatment of autistic persons: a review of research from 1980 to the present. Res Dev Disabil 1996;17:433–465.
467. Quill K. Enhancing children’s social-communicative interactions. Teaching children with autism: strategies to enhance communication and socialization. New York: Delmar, 1995:163–192.
468. Rutter M. Infantile autism. In: Shaffer D, Ehrhardt AA, Greenhill LL, eds. The clinical guide to child psychiatry. New York: Free Press, 1985:48–78.
469. Cohen DJ, Volkmar FR. Autism and pervasive developmental disorders: a handbook. New York: John Wiley, 1997.
470. Gillberg C, Johansson M, Steffenberg S, et al. Auditory integration training in children with autism: brief report of an open pilot study. Autism 1997;1:97–100.
471. Bettison S. The long-term effects of auditory training in children with autism. J Autism Dev Disord 1996;26:361–374.
472. Bebko JM, Perry A, Bryson S. Multiple method validation study of facilitated communication. II. Individual differences and subgroup results. J Autism Dev Disord 1996;26:19–42.
473. Howlin P. Prognosis in autism: do specialist treatments affect outcome? Eur Child Adolesc Psychiatry 1997;6:55–72.
474. Horvath K, Stefanatos G, Sokolski KN, et al. Improved social skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys 1998;9–15.
475. American Academy of Pediatrics. The Doman-Delacato treatment of neurologically handicapped children. Pediatrics 1982;70:810–812.
476. Mason SM, Iwata BA. Artifactual effects of sensory integrative therapy on self-injurious behaviour. J Appl Behav Anal 1990;26:361–370.
477. Hoehn TP, Baumeister M. A critique of the application of sensory integration therapy to children with learning disabilities. J Learn Disabil 1994;27:338–350.
478. Burden V, Stott CM, Forge J, et al. The Cambridge Language and Speech Project (CLASP). I. Detection of language difficulties at 36 to 39 months. Dev Med Child Neurol 1996;38:613–631.
479. Tomblin JB, Records NL, Buckwalter P, et al. Prevalence of specific language impairment in kindergarten children. J Speech Lang Hear Res 1997;40:1245–1260.
480. Stem LM, Connell TM, Lee M, et al. Adelaide preschool language unit: results of follow-up. J Paediatr Child Health 1995;31:207–212.
481. Silva PA, Williams S, McGee R. A longitudinal study of children with developmental language delay at age three: later intelligence, reading, and behaviour problems. Dev Med Child Neurol 1987;29:630–640.
482. Werker JF. The effects of multilingualism on phonetic perceptual flexibility. Appl Psycholinguis 1986;7:141–156.
483. Lenneberg EH, Rebelsky FG, Nichols IA. The vocalization of infants born to deaf and to hearing parents. Vita Humana 1965;8:23–37.
484. Franco F, Butterworth G. Pointing and social awareness: declaring and requesting in the second year. J Child Lang 1996;307–336.
485. Bates E, Thal D, Janowsky JS. Early language development and its neural correlates. In: Segalowitz SJ, Rapin I, eds. Handbook of neuropsychology, Vol. 7. New York: Elsevier Science, 1992:69–110.
486. Capute AJ, Accardo PJ. Linguistic and auditory milestones during the first two years of life: a language inventory for the practitioner. Clin Pediatr 1978;17:847–853.
487. Thal D, Tobias S, Morrison D. Language and gestures in late talkers: a one-year follow-up. J Speech Hear Disord 1991;34:604–612.
488. Tallal P, Stark RE, Mellits ED. Identification of language-impaired children on the basis of rapid perception and production skills. Brain Lang 1985;25:314–322.
488a. Silva DA, Satz P. Pathological left-handedness: evaluation of a model. Brain & Lang 1979;7:8–16.
489. Nass R. Language development in children with congenital strokes. Semin Pediatr Neurol 1997;4:109–116.
489a. Vicari S, Chilosi AM, et al. Plasticity and reorganization during language development in children with early brain injury. Cortex 2000;36:31–46.
489b. Jonas R, Nguyen S, Hu B, et al. Cerebral hemispherectomy: hospital course, seizure, developmental language and motor outcome. Neurol 2004;62:1712–1721.
490. Woods BT, Teuber HL. Changing patterns of childhood aphasia. Ann Neurol 1978;3:273–280.
491. Vargha-Khadem F, Isaacs EB, Papleloudi H. Development of language in six hemispherectomized patients. Brain 1991;114:473–495.
492. Dall’Oglio AM, Bates E, Volterra V, et al. Early cognition, communication, and language in children with focal brain injury. Dev Med Child Neurol 1994;36:1076–1098.
493. Hiscock M, Kinsbourne M. Phylogeny and ontogeny of cerebral lateralization. In: Davidson R, Hugdahl K, eds. Brain asymmetry. Cambridge, MA: MIT Press, 535–578.
494. Duchowny M, Jayakar P, Harvey AS, et al. Language cortex representation: effects of developmental versus acquired pathology. Ann Neurol 1996;40:37–38.
495. Chugani HT, Phelps ME, Mazziotta JC. Positron emission tomography of human brain functional development. Ann Neurol 1987;22:487–497.
496. Huttenlocher PR. Morphometric study of human cerebral cortex development. Neuropsychologia 1990;28:517–527.
497. Aram DM, Eisele JA. Intellectual stability in children with unilateral brain lesions. Neuropsychologia 1994;32:85–95.
498. Bates E, Thal D, Trauner D, et al. From first words to grammar in children with focal brain injury. Dev Neuropsych 1997;13:275–343.
499. Muter V, Taylor S, Vargha-Khadem F. A longitudinal study of early intellectual development in hemiplegic children. Neuropsychologia 1997;35:289–299.
500. Ramachandran VS. Behavioral and magnetoencephalographic correlates of plasticity in the adult human brain. Proc Nat Acad Sciences 1993;90:10413–10420.
501. Weiller C, Isenee C, Rijntjesz M, et al. Recovery from Wernicke’s aphasia: a positron emission tomography study. Ann Neurol 1995;37:723–732.
502. Wada J, Rasmussen T. Intracarotid injections of sodium amytal for clinical observations. J Neurosurg 1960;17:266–282.
503. Kinsbourne M. The minor cerebral hemisphere as a source of aphasic speech. Arch Neurol 1971;25:302–306.
504. Chiarello C. A house divided? Cognitive functioning with callosal agenesis. Brain Lang 1980;11:128–158.
505. Nass R, Koch D. Differential effects of early unilateral brain damage on temperament. Dev Neuropsychol 1987;3:93–99.
506. Schmahmann JD, Sherman JC. The cerebellar cognitive-emotional syndrome. Brain 1998;121:561–579.
507. Riva D, Giorgi C. The cerebellum contributes to higher functions during development. Brain 2000;123:1051–1061.
508. Gottwald B, Wilde B, Mihajlovic Z, et al. Evidence for distinct cognitive deficits after focal cerebellar lesions. J Neurol Neurosurg Psychiatry 2004;75:1524–1531.
509. Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children. Brain 2000;123:1041–1050.
510. Guzzetta F, Mercuri E, Bonanno S, et al. Autosomal recessive congential cerebellar atrophy: a clinical and neuropsychological study. Brain Dev 1993;15:439–445.
511. Travis LS. Handbook of speech pathology and audiology. New York: Appleton-Century-Crofts, 1971.
512. Kools JA, Williams AF, Vickers MJ, et al. Oral and limb apraxia in mentally retarded children with deviant articulation. Cortex 1971;7:387–400.
513. Braun AR, Varga M, Stager S, et al. Altered patterns of cerebral activity during speech and language production in developmental stuttering. An H2(15)O positron emission tomography study. Brain 1997;120:761–784.
514. Fox PT, Ingham RJ, Ingham JC, et al. A PET study of the neural systems of stuttering. Nature 1996;382:158–161.
515. Bishop DVM. Handedness and developmental disorder: clinics in developmental medicine. Oxford: Blackwell Science, 1990:110.
516. Hancock K, Craig A, McCready C, et al. Two- to six-year controlled-trial stuttering outcomes for children and adolescents. J Speech Lang Hear Res 1998;41:1242–1252.
517. DeFusio EN, Menken M. Symptomatic cluttering in adults. Brain Lang 1979;8:25–33.
518. Mathinos DA. Communication competence of children with learning disabilities. J Learn Disabil 1988;21:437–443.
519. Kinsbourne M. The neuropsychology of bilingualism. Ann NY Acad Sci 1981;379:50–58.
520. Singh JA, Zingg RM. Wolf children and feral man. New York: Harper & Row, 1942.
521. Davis K. Final note on a case of extreme isolation. Am J Sociol 1947;52:432.
522. Curtis S. Genie: a psycholinguistic study of a modern day “Wild Child.” New York: Academic Press, 1977.
523. Johnson J, Newport E. Critical period effects in second language learning: the influence of maturational state on the acquisition of English as a second language. Cogn Psychol 1989;21:60–99.
524. Stein DG, Brailovsky S, Will B. Brain repair. New York: Oxford University Press, 1995.
525. Mogford K. Oral language acquisition in the prelinguistically deaf. In: Bishop D, Mogford K, eds. Language development in exceptional circumstances. Edinburgh: Churchill Livingstone, 1988:110–131.
526. Mayberry RI, Eichen EB. The long-lasting advantage of learning sign language in childhood: another look at the critical period for language acquisition. J Mem Lang 1991;30:486–512.
527. Poizner J, Klima ES, Bellugi U. What the hands reveal about the brain. Cambridge, MA: MIT Press, 1987.
528. Mayer P, Lowenbraun S. Total communication use among elementary teachers of hearing-impaired children. Am Ann Deaf 1990;135:257–263.
529. Kaplan P. Pathways for exceptional children. Minneapolis, MN: West, 1996.
530. Gascon GG, Johnson R, Burd L. Central auditory processing and attention deficit disorders. J Child Neurol 1986;1:27–33.
531. Klein SK, Rapin I. Intermittent conductive hearing loss and language development. In: Bishop D, Mogford K, eds. Language development in exceptional circumstances. London: Churchill Livingstone, 1988:96–109.
532. Spencer LJ, Gantz BJ, Knutson JF. Outcomes and achievements of students who grew up with access to cochlear implants. Laryngoscope 2004;114:1576–1581.
532a. Tomblin JB, Records N, Buck water P, et al. Prevalence of specific language impairment in children. J Speech and Hearing Research 1997;39:1284–1294.
533. Leonard LB. Children with specific language impairment. Cambridge, MA: MIT Press, 1998.
534. Silva PA, McGee R, Williams S. Developmental language delay from three to seven years and its signficance for low intelligence and reading difficulties at age seven. Dev Med Child Neurol 1983;25:783–793.
535. Rapin I, Allen DA. Developmental language disorders: nosological considerations. In: Kirk U, ed. Neuropsychology of language, reading, and spelling. New York: Academic Press, 1983:155–184.
536. Tallal P, Stark RE, Mellits D. The relationship between auditory temporal analysis and receptive language development: evidence from studies of developmental language disorder. Neuropsychologia 1985;23:527–534.
537. Bishop DMV. The underlying nature of specific language impairment. J Child Psychol Psychiat 1992;23:3–66.
538. Cohen M, Campbell R, Yaghmai F. Neuropathological abnormalities in developmental dysphasia. Ann Neurol 1989;25:567–570.
539. Shields J, Varley R. Broks P, et al. Social cognition in developmental language disorders and high-level autism. Dev Med Child Neurol 1996;38:487–495.
540. Shields J, Varley R, Broks P, et al. Hemispheric function in developmental language disorders and autism. Dev Med Child Neurol 1996;38:473–486.
541. Hurst JA, Baraitser M, Auger E, et al. An extended family with an inherited speech disorder. Dev Med Child Neurol 1990;32:347–355.
542. Stromswold K. The heritability of language: a review and meta-analysis of twin, adoption and linkage studies. Language 2001;77:647–723.
543. Bishop DV. Motor immaturity and specific speech and language impairment: evidence for a common genetic basis. Am J Med Genet 2002;8:56–63.
543a. Marcus GF, Fisher SE. FOXP2 in focus: what can genes tell us about speech and language? Trends in Cognitive Sciences 2003;7:257–262.
544. Beichtman JH, Nair R, Clegg M, et al. Prevalence of psychiatric disorders in children with speech and language disorders. J Am Acad Child Adolesc Psychiatry 1993;32:595:603.
545. Willinger U, Brunner E, Diendorfer-Radner G, et al. Behaviour in children with language developmental disorders. Can J Psychiatry 2003;48:607–614.
546. Van Hout A. Acquired aphasia in children. Semin Pediatr Neurol 1997;4:102–108.
547. Cranberg LD, Filley CM, Hart EJ, et al. Acquired aphasia in childhood: clinical and CT investigations. Neurology 1987;37:1165–1172.
548. Stiles J. The effect of early brain injury on lateralization of cognitive function. Curr Direct Psychol Science 1998;7:21–26.
549. Liegeois F, Connelly A, Cross JH, et al. Language reorganization in children with early-onset lesions of the left hemisphere: an fMRI study. Brain 2004;127:1229–1236.
550. Van Dongen HR, Loonen MCB. Factors related to prognosis of acquired aphasia in children. Cortex 1977;13:131–136.
551. Cooper JA, Flowers CR. Children with a history of acquired aphasia: residual language and academic impairment. J Speech Hear Disord 1987;52:251–262.
552. Stefanatos GA, Kinsbourne M, Wasserstein J. Acquired epileptiform aphasia: a dimensional view of Landau-Kleffner syndrome and the relation to regressive autistic spectrum disorder. Child Neuropsychology 2002;8:195–228.
553. da Silva EA, Chugani DC, Muzik O, et al. Landau-Kleffner syndrome: metabolic abnormalities in temporal lobe are a common feature. J Child Neurol 1997;12:489–495.
554. Appleton RE. The Landau-Kleffner syndrome. Arch Dis Child 1995;72:386–387.
555. Lahey M. Who shall be called language disordered? Some reflections and one perspective. J Speech Hear Disord 1990;55:612–620.
556. Binnie CD, Kasteleijn-Nolst Trenite DG, Smit AM, et al. Interactions of epileptiform EEG discharges and cognition. Epilepsy Res 1987;1:239–245.
557. Kim KHS, Relkin NR, Lee KM, et al. Distinct cortical areas associated with native and second languages. Nature 1997;388:171–174.
558. Friedrich U, Dalby M, Staehelin-Jensen T, et al. Chromosomal studies of children and developmental language retardation. Dev Med Child Neurol 1982;24:645–652.
559. Ratcliffe SG. Speech and learning disorders in children with sex chromosome abnormalities. Dev Med Child Neurol 1982;24:80–84.
560. Mazzocco MM, Myers GF, Hamner JL, et al. The prevalence of the FMR1 and FMR2 mutations among preschool children with language delay. J Pediatr 1998;132:795–801.
561. Cantwell DP, Baker C. Association between attention-deficit hyperactivity disorder and learning disorders. J Learn Disabil 1991;24:88–95.
562. Allen DA, Mendelson L, Rapin I. Syndrome-specific remediation in preschool developmental dysphasia. In: French JH, Havel S, Casser P, eds. Child neurology and developmental disabilities. Baltimore: Brooks, 1989:233–243.
563. Tallal P. Developmental language disorders. In: Kavanagh JF, Truss TJ, eds. Learning disorders. Parkton, MD: York Press, 1988:181–272.
564. Law J, Garrett Z, Nye C. The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis. J Speech Lang Hear Res 2004;47:924–943.
565. Owens RE, House LI. Decision-making process in augmentative communication. J Speech Hearing Disord 1984;47:18–25.
566. Amir N, Seligman-Wine J, Gross-Tsur V. The role of augmentative communication in impaired language acquisition. In: Amir N, Rapin I, Bianski D, eds. Pediatric neurology: behavior and cognition of the child with brain dysfunction, Vol 1. Basel: Karger, 1991:129–145.
567. Bilken D. Communication unbound. Harv Educ Rev 1990;60:291–314.
568. Cummus RA, Prior MP. Autism and assisted communication: a response to Bilken. Harv Educ Rev 1992;62:228–241.
569. Kavanagh JF, Truss TJ. Learning disabilities. Parkton, MD: York Press, 1988.
570. Lyon GR. Toward a definition of dyslexia. Ann Dyslexia 1995;45:3–27.
570a. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Geneva, World Health Organization.
571. Siegel L. IQ is irrelevant to the definition of learning disabilities. J Learn Disabil 1989;22:469–478.
572. Meyer MS. The ability-achievement discrepancy: does it contribute to an understanding of learning disabilities? Edu Psychol Rev 2000;12:315–337.
573. Flowers L, Meyer M, Lovato J, et al. Does third grade discrepancy status predict the course of reading development? AnnDyslexia 2001;50:1–23.
574. Lyon GR, Fletcher JM, Shaywitz SE, et al. Rethinking learning disabilities. In: Finn CE Jr, Rotherham AJ, Hokanson CR Jr, eds. Rethinking special education for a new century. Washington, DC: Thomas B. Fordham Foundation and the Progressive Policy Institute, 2001:259–287.
575. Willcutt EG, Pennington BF. Psychiatric comorbidity in children and adolescents with reading disability. J Child Psychol Psychiatry, 2000;41:1039–1048.
576. Wood FB, Felton RF. Separate linguistic and attentional factors in the development of reading. Top Lang Disord 1994;14(4):42–57.
577. Knopik VS, De Fries JC. Etiology of covariation between reading and mathematics performance: a twin study. Twin Res (Engl), 1999;2:226–34.
578. Moores DF. Educating the deaf: psychology, principles, and practices, 3rd ed. Boston: Houghton-Mifflin, 1987.
579. Ross M. Hard-of-hearing children in regular schools. Englewood Cliffs, NJ: Prentice-Hall, 1982.
580. Stein PA, Hoover JH. Manifest anxiety in children with learning disabilities. J Learn Disabil 1989;22:66–71.
581. Smith SL. Succeeding against the odds: how the learning disabled can realize their promise. New York, NY: G. P. Putnum’s Sons, 1991.
582. Casey R, Levy SE, Brown K, et al. Impaired emotional health in children with mild reading disability. J Dev Behav Pediatr 1992;13:256–260.
583. Prior M, Smart D, Sanson A, et al. Relationships between learning difficulties and psychological problems in preadolescent children from a longitudinal sample. J Am Acad Child Adolesc Psychiatry 1999;38:429–436.
584. Maughan B, Rowe R, Loeber, R, et al. Reading problems and depressed mood. J Abnorm Child Psychol 2003;31:219–229.
585. Fristad MA, Topolosky S, Weller EB, et al. Depression and learning disabilities in children. J Affect Disord 1992;26:53–58.
586. Handwerk ML, Marshall RM. Behavioral and emotional problems of students with learning disabilities, serious emotional disturbance, or both conditions. J Learn Disabil 1998;31:327–338.
587. Maag JW, Behrens JT. Depression and cognitive self statements of learning disabled and seriously emotionally disturbed adolescents. J Spec Ed 1989;23:17–27.
588. Svetaz MV, Ireland M, Blum R. Adolescents with learning disabilities: risk and protective factors associated with emotional well being: findings from the National Longitudinal Study of Adolescent Health. J Adolesc Health 2000;27:340–348.
589. Wood F, Goldston D. Learning disabilities: a hidden source of suicidal thought and behaviour. In: Schlebusch L, Bosch BA, eds. Suicidal behavior 4. Proceedings of the Southern African conference on suicidology, Durban, South Africa.
590. Willcutt EG, Pennington BF. Psychiatric comorbidity in children and adolescents with reading disability. J Child Psychol Psychiat 2000;41:1039–1048.
591. Wright-Strawderman C, Watson BL. The prevalence of depressive symptoms in children with learning disabilities. J Learn Disabil 1992;25:258–264.
592. U. S. Department of Education. 17th annual report to Congress on the implementation of IDEA.
593. Shaywitz SE, Shaywitz BA, Fletcher JM, et al. Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA 1990;264:998–1002.
595. Nichols PL, Chen TC. Minimal brain dysfunction: a prospective study. Hillsdale, NJ: Erlbaum, 1981.
596. Liberman IY, Shankweiler D, Liberman AM. The alphabetic principle and learning to read. In: Shankweiler D, Liberman IY, eds. Phonology and reading disability: solving the reading puzzle. Ann Arbor, MI: University of MI Press, 1989:1–33.
597. Stanovitch K. Explaining the variance in reading ability in terms of psychological processes: what have we learned? Ann Dyslexia 1986;35:67–96.
598. Stevenson H. Orthography and reading disabilities. J Learn Disabil 1984;18:132–135.
599. Rutter M, Yule W. The concept of specific reading retardation. J Child Psychol Psychiatry 1975;16:181–197.
600. Nelson HE, Warrington EK. Developmental spelling retardation. In: Knights RM, Bakker DJ, eds. The neuropsychology of learning disorders: theoretical approaches. Baltimore: University Park Press, 1976:325–332.
601. Lyon GR. Research initiatives in learning disabilities: contributions from scientists supported by the National Institute of Child Health and Human Development. J Child Neurol 1995;10:120–S126.
602. Gleitman LR, Rozin P. The structure and acquisition of reading. I. Relations between orthographies and the structure of language. In: Reber AJ, Scarborough DL, eds. Toward a psychology of reading. Hillsdale, NJ: Erlbaum, 1977.
603. Bradley L, Bryant P. Categorizing sounds and learning to read—a causal connection. Nature 1983;301:419–421.
604. Tallal P. Auditory temporal perception, phonics, and reading disabilities in children. Brain Lang 1980;9:182–198.
605. Eden GF, Stein JF, Wood HM, et al. Temporal and spatial processing in reading disabled and normal children. Cortex 1995;31:451–468.
606. Reynolds AM, Elkonin N, Brown FRI. Specific reading disabilities: early identification and long-term outcome. MRDD Res Rev 1996;2:21–27.
607. Denckla M. Motor coordination in dyslexic children. In: Duffy F, Geschwind N, eds. Dyslexia. Boston: Little, Brown and Company, 1987.
608. Duffy FH, Denckla MB, Bartels PH, et al. Dyslexia: automated diagnosis by computerized classification of brain electrical activity. Ann Neurol 1980;7:421–428.
609. Lou HC, Hendrikson L, Bruhn P. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurol 1984;41:825–829.
610. Galaburda AM, Sherman GF, Rosen GD, et al. Developmental dyslexia: four consecutive patients with cortical anomalies. Ann Neurol 1985;18:222–233.
611. Denckla MB, LeMay M, Chapman CT. No CT scan abnormalities found even in neurologically impaired learning disabled children. J Learn Disabil 1985;18:132–135.
611a. EcKert M. Neuroanatomical markers for dyslexia: A review of dyslexia structural imaging studies. The Neuroscientist 2004;10:362–371.
612. Johnson D, Balock J. Adults with learning disabilities. Orlando: Grune & Stratton, 1987.
613. Kinsbourne M, Rufo DT, Gamzu E, et al. Neuropsychological deficits in adults with dyslexia. Dev Med Child Neurol 1991;33:763–775.
614. Felton R, Naylor C, Wood F. Neuropsychological profile of adult dyslexics. Brain Lang 1990;39:485–497.
615. Wood FB, Flowers Dl, Grigorenko E. The functional neuroanatomy of fluency or why walking is just as important to reading as talking is. In: Wolf M, ed. Dyslexia, fluency, and the brain. Baltimore, MD: York Press, 2001:235–244.
616. Pugh KR, Mencl WE, Jenner AR, et al. Neurobiological studies of reading and reading disability. J Commun Disord (USA), Nov–Dec 2001;34:479–492).
617. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Functional disruption in the organization of the brain for reading in dyslexia. Proc Nat Acad Sci USA 1998;95:2636–2641.
618. Flowers DL, Wood FB, Naylor CE. Regional cerebral blood flow correlates of language processes in reading disability. Arch Neurol 1991;48:637–643.
619. Gross-Glenn K, Duara R, Barker WW, et al. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults. J Clin Exp Neuropsychol 1991;13:531–544.
620. Rumsey JM, Andreason P, Zametkin AJ, et al. Right frontotemporal activation by tonal memory in dyslexia, an O15 PET study. Biol Psychiatry 1994;36:171–180.
621. Rumsey JM, Zametkin AJ, Andreason P, et al. Normal activation of frontotemporal language cortex in dyslexia as measured with oxygen 15 positron emission tomography. Arch Neurol 1994;51:27–38.
622. Rumsey JM, Nace K, Donohue B, et al. A positron emission tomographic study of impaired word recognition and phonological processing in dyslexic men. Arch Neurol 1997;54:562–573.
623. Eden GF, Jones KM, Cappell K, et al. Neural changes following remediation in adult developmental dyslexia [in process citation] Neuron (USA), 2004;44:411–422.
624. Torgeson J. Catch them before they fall. The American educator. Spring/Summer, 1998.
625. Maughan B. Annotation: long-term outcomes of developmental reading problems. J Psychol Psychiatry 1995;36:357–371.
626. Thomas CJ. Congenital “word blindness” and its treatment. Ophthalmoscope 1905;3:380–385.
627. Hallgren B. Specific dyslexia (congenital word-blindness); a clinical and genetic study. Acta Neurol Scand Suppl 1950;65:1–287.
628. Yule W, Rutter M. Reading and intelligence. In: Knights R, Bakker J, eds. Neuropsychology of language disorders: theoretical approaches. Baltimore: University Park Press, 1976.
629. Finucci JM, Whitehouse CC, Isaacs SD, et al. Derivation and validation of a quantitative definition of specific reading disability for adults. Dev Med Child Neurol 1984;26:143–153.
630. Pennington BF. Using genetics to understand dyslexia. Ann Dyslexia 1989;39:81–93.
631. Tzenova J, Kaplan BJ, Petryshen TL, et al. Confirmation of a dyslexia susceptibility locus on chromosome 1p34-p36 in a set of 100 Canadian families. Am J Med Genet 2004;127B:117–124.
632. Fagerheim T, Raeymaekers P, Tonnessen FE, et al. A new gene (DYX3) for dyslexia is located on chromosome 2. J Med Genet 1999;36:664–669.
633. Fisher SE, Francks C, Marlow AJ, et al. Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat Genet 2002;30:86–91.
634. Deffenbacher KE, Kenyon JB, Hoover DM, et al. Refinement of the 6p21.3 quantitative trait locus influencing dyslexia: linkage and association analyses. Hum Genet 2004;115:128–138.
635. Morris DW, Robinson L, Turic D, et al. Family-based association mapping provides evidence for a gene for reading disability on chromosome 15q. Hum Mol Genet 2000;9:843–848.
636. Finucci J, Childs B. Are there really more dyslexic boys than girls? In: Ansarer A, Geschwind N, Galaburda A, eds. Sex differences in dyslexia. Baltimore, MD: The Orton Society, 1981.
637. Grigorenko EL, Wood FB, Meyer MS, et al. Susceptibility loci for distinct components of developmental dyslexia on chromosomes 6 and 15. Am J Hum Genet 1997;60:27–39.
638. Fagerheim T, Raeymaekers P, Tonnessen FE, et al. A new gene (DYX3) for dyslexia is located on chromosome 2. J Med Genet 1999;36:664–669.
638a. Bishop DVM, Snowling MJ. Developmental dyslexia and specific language impairment: Same or different? Psychol Bull 2004;130:858–886.
639. Harnadek MC, Rourke BP. Principal identifying features of the syndrome of nonverbal learning disabilities in children. J Learn Disabil 1994;27:144–154.
640. Geary DC. Mathematics and learning disabilities. J Learn Disabil 2004;37:4–15.
641. Satz P, Morris R. Learning disability subtypes: a review. In: Pirozzolo FJ, Wittrock MC, eds. Neuropsychologic and cognitive processes in reading. New York: Academic Press, 1981.
642. Geiger G, Lettvin JY. Peripheral vision in persons with dyslexia. N Engl J Med 1987;316:1238–1243.
643. Slaghuis WL, Lovegrove WJ. Spatial-frequency-dependent visible persistence and specific reading disability. Brain Cogn 1985;4:219–240.
644. Livingstone MS, Rosen GD, Drislane FW, et al. Physiological and anatomical evidence for a magnocellular defect in developmental dyslexia. Proc Nat Acad Sci USA 1991;88:7943–7947.
645. Lehmkuhle S, Garzia RP, Turner L, et al. A defective visual pathway in children with reading disability. N Engl J Med 1993;328:989–996.
645a. Greatrex JC, Drasdo N. The magnocellular deficit hypothesis in dyslexia: A review of reported evidence. Opthal and Physiol Optics 1995;15:501–506.
645b. Skottum BC. The magnocellular deficit theory of dyslexia: The evidence from contrast sensitivity. Vision Res 40:111–127.
646. Wolf M, Bowers PG. Naming-speed processes and developmental reading disabilities: an introduction to the special issue on the double-deficit hypothesis. J Learn Disabil 2000;33:322–324.
647. Huff E, Sorenson J, Dancer J. Relation of reading rate and rapid automatic naming in third graders. Percept Mot Skills 2002;95:925–926.
648. Meyer MS, Wood FB, Hart LA, et al. Selective predictive value of rapid automatized naming in poor readers. J Learn Disabil 1998;31:106–117.
649. Kinsbourne M, Warrington EK. Developmental factors in reading and writing backwardness. Br J Psychol 1963;54:145–156.
650. Kinsbourne M, Warrington EK. The development of finger differentiation. Quarterly J Exper Psychol 1964;15:132–137.
651. Hicks RE, Kinsbourne M. On the genesis of human handedness: a review. J Mot Behav 1976;8:257–266.
652. Geschwind N, Behan P. Left-handedness: association with immune disease, migraine, and developmental learning disorder. Proc Natl Acad Sci USA 1982;79:5097–5100.
653. Crawford SG, Kaplan BJ, Kinsbourne M. The effects of parental immunoreactivity on pregnancy, birth, and cognitive development: maternal immune attack on the fetus? Cortex 1992;28:483–491.
654. Gilger JW, Pennington BF, Harbeck RJ, et al. A twin and family study of the association between immune system dysfunction and dyslexia using blood serum immunoassay and survey data. Brain Cogn 1998;36:310–333.
655. Porac C, Cohen S. Lateral preferences and human behavior. New York: Springer-Verlag, 1981.
656. Hiscock M, Kinsbourne M. Progress in the measurement of laterality and implications for dyslexia research. Ann Dyslexia 1995;45:249–268.
657. Schultz RT, Cho NK, Staib LH, et al. Brain morphology in normal and dyslexic children: the influences of sex and age. Ann Neurol 1994;35:732–742.
658. Leonard CM, Voeller KK, Lombardino LJ, et al. Anomalous cerebral structure in dyslexia revealed with magnetic resonance imaging. Arch Neurol 1993;50:461–469.
659. Geschwind DH, Dykens E. Neurobehavioral and psychosocial issues in Klinefelter syndrome. Learn Disabil Res Prac 2004;19:166–173.
660. Hinton VJ, DeVivo DC, Fee R, et al. Investigation of poor academic achievement in children with Duchenne muscular dystrophy. Learn Disabil Res Prac 2004;19:146–154.
661. Stein JF, Riddell PM, Fowler S. Disordered vergence control in dyslexic children. Br J Ophthalmol 1988;72:162–166.
662. Comelissen P, Bradley L, Fowler S, et al. Covering one eye affects how some children read. Dev Med Child Neurol 1992;34:296–304.
663. Polatajko HJ. A critical look at vestibular dysfunction in learning disabled children. Dev Med Child Neurol 1985;27:283–292.
664. Ball EW, Blachman BA. Does phoneme awareness training in kindergarten make a difference in early word recognition and development of spelling? Read Res Quart 1991;26:49–66.
665. Meyer MS, Felton RH. Repeated reading to enhance fluency: old approaches and new directions. Ann Dyslexia 1999;49:284–306.
666. The 1986/87 Future of Visual Development/Performance Task Force Special Report. The efficacy of optometric vision therapy. J Am Optom Assoc 1988;59:95–105.
667. Carte E, Morrison D, Sublett J, et al. Sensory integration therapy: a trial of a specific neurodevelopmental therapy for the remediation of learning disabilities. J Dev Behav Pediatr 1984;5:189–194.
668. Cummins RA. Sensory integration and learning disabilities: Ayers’ factor analyses reappraised. J Learn Disabil 1991;24:160–168.
669. Tomatis A. Education and dyslexia. France, Quebec: Les Editions, 1978.
670. Aman MG, Werry JS. Methylphenidate and diazepam in severe mental retardation. J Am Acad Child Adolesc Psychiatry 1982;21:31–37.
671. Levinson HN. A solution to the riddle dyslexia. New York: Springer-Verlag, 1980.
672. Fagan JE, Kaplan BJ, Raymond JE, et al. The failure of antimotion sickness medication to improve reading in developmental dyslexia: results of a randomized trial. J Dev Behav Pediatr 1988;9:359–366.
673. McMahon JR, Gross RT. Physical and psychological effects of aerobic exercise in boys with learning disabilities. J Dev Behav Pediatr 1987;8:274–277.
674. Kohen-Raz RL. Learning disabilities and postural control. London: Freund, 1986.
675. American Academy of Ophthalmology. Learning disabilities and children: what parents need to know. San Francisco: American Academy of Ophthalmology, 1984.
676. Delacato CH. The diagnosis and treatment of speech and reading problems. Springfield, IL: Charles C Thomas, 1963.
677. Felton RH. Effects of instruction on the decoding skills of children with phonological-processing problems. J Learn Disabil (USA) 1993;26:583–589.
678. Foorman BR, Francis DJ, Fletcher JM, et al. The role of instruction in learning to read: preventing reading failure in at-risk children. J Edu Psychol 1998;90:37–55.
679. Juel C. What makes literacy tutoring effective? Read Res Quart 1996;31:268–289.
680. Fayol M, Barrouillet P, Mrinthe C. Predicting arithmetical achievement from neuropsychological performance: a longitudinal study. Cognition 1998;68:63–70.
681. Rourke B, Finlayson M. Neuropsychological significance of variations in patterns of academic performance: verbal and visuospatial abilities. J Abnorm Child Psychol 1978;6:121–133.
682. Shalev RS, Wurtmann R, Amir N. Developmental dyscalculia. Cortex 1988;24:555–561.
683. Ackerman P, Anhalt J, Dykman R. Arithmetic automatization failure in children with attention and reading disorders: associations and sequela. J Learn Disabil 1986;19:222–232.
684. Shalev RS, Manor O, Auerbach J, et al. Persistence of developmental dyscalculia: what counts? Results from a 3-year prospective follow-up study. J Pediatr 1998;133:320–321.
685. Shalev RS. Developmental dyscalculia. J Child Neurol 2004;19:756–771.
686. Chandler HN. Confusion confounded: a teacher tries to use research results to teach maths. J Learn Disabil 1987;11:361–369.
687. Semrud-Clikeman M, Hynd GW. Right hemisphere dysfunction in nonverbal learning disabilities: social, academic, and adaptive functioning in adults and children. Psychol Bull 1990;107:196–209.
688. Levin HS, Scheller J, Rickard T, et al. Dyscalculia and dyslexia after right hemisphere injury in infants. Arch Neurol 1996;53:88–96.
689. Cleaver RL, Whitman RD. Right hemisphere, white matter learning disabilities associated with depression in an adolescent amd young adult psychiatric population. J Nerv Ment Dis 1998;186:561–565.
690. Mattson AJ, Sheer DE, Fletcher JM. Electrophysiological evidence of lateralized disturbances in children with learning disabilities. J Clin Exp Neuropsychol 1992;14:707–716.
691. Pennington BF, van Doorninck WJ. Neuropsychological deficits in early treated phenylketonuric children. Am J Ment Def 1985;89:467–474.
692. Rovet J. Turner syndrome: genetic and hormonal factors contributing to a specific learning disability profile. Learn Disabil Res Prac 2004;19:133–145.
693. Swillen A, Devriendt K, Legius E, et al. The behavioural phenotype in velo-cardio-facial syndrome in adolescence. Genet Couns 1999;10:79–88.
694. Pennington BF. Genetics of learning disabilities. Semin Neurol 1991;11:28–34.
695. Aldenkamp HP, Alpherts WC, Dekker MJ, et al. Neuropsychological aspects of learning disabilities in epilepsy. Epilepsia 1990;31 [Suppl 4]:9–20.
696. Eliason MJ. Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1987;6:17–25.
697. Cutting LE, Clements AM, Lightman AD, et al. Cognitive profile of neurofibromatosis type 1: rethinking nonverbal learning disabilities. Learn Disabil Res Prac 2004;19:155–165.
698. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999;89:45–52.
699. North K, Joy P, Yuille D, et al. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 1994;44:878–883.
700. Sevick RJ, Barkovich AJ, Edwards MS, et al. Evolution of white-matter lesions in neurofibromatosis type 1: MR findings. Am J Roentgenol 1992;159:171–175.
701. Denckla MB. Neurofibromatosis type 1: a model for the pathogenesis of reading disability. MRDD Res Rev 1996;2:48–53.
702. Gresham FM, Reschly DJ. Social skills, deficits and low peer acceptance of mainstreamed learning disabled children. Learn Disabil Quart 1986;9:23–32.
703. Dudley-Marling C, Edmiaster R. Social status of learning disabled children and adolescents: a review. Learn Disabil Quart 1985;8:189.
704. Hazel JS, Schumaker JB. Social skills and learning disabilities: current issues and recommendations for future research. In: Kavanagh F, Truss TJ, eds. Learning disabilities: proceedings of the national conference. Parkton, MD: York Press, 1988:293–344.
705. Cratty BJ. Clumsy child syndromes: descriptions, evaluation and remediation. USA: Harwood Academic Publishers, 1994.
706. Smyth TR. Clumsiness: kinaesthetic perception and translation. Child Care Health Dev 1996;22:1–9.
707. Wilson PH, MacKenzie BE. Information processing deficits associated with developmental coordination disorder: a meta-analysis of research findings. J Child Psychol Psychiatry 1998;39:829–240.
708. Mandich A, Buckolz E, Polatajko H. On the ability of children with developmental coordination disorder (DCD) to inhibit response initiation: the Simon effect. Brain Cogn 2002;50:1501–1512.
709. Rasmussen P, Gilberg C. Natural outcomes of ADHD with developmental coordination disorder at age 22 years. A controlled longitudinal community-based study. J Acad Child Adolesc Psychiatry 2000;39:1424–1431.
710. Pitcher TM, Piek JP, Hay DA. Fine and gross motor ability in males with ADHD. Dev Med Child Neurol 2003;45:525–535.
711. Deuel RK. Developmental dysgraphia and motor skill disorder. J Child Neurol 1994;10:6–8.
712. Schoemaker MM, Hijlkema MGJ, Kalverboer AF. Physiotherapy for clumsy children: an evaluation study. Dev Med Child Neurol 1994;36:143–155.
713. Willcutt EG, Pennington BF, DeFries JC. Etiology of inattention and hyperactivity/impulsivity in a community sample of twins with learning disabilities. J Abnorm Child Psychol 2000;28:149–159.
714. DeQuiros GB, Kinsbourne M, Palmer RL, et al. Attention deficit disorder in children: three clinical variants. J Devel Behav Pediatrics 1994;15:311–319.
715. Rappley MD. Attention deficit-hyperactivity disorder. N Engl J Med 2005;352:165–173.
716. Applegate B, Lahey BB, Hart EL, et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J Am Acad Child Adolesc Psychiatry 1997;36:1211–1221.
717. Kaplan BJ, McNicol J, Conte RA, et al. Sleep disturbances in preschool-aged hyperactive and nonhyperactive children. Pediatrics 1987;80:839–844.
718. Chervin RD, Dillon JE, Bassetti C, et al. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep 1997;20:1185–1192.
719. Palfrey JS, Levine MD, Walker DK, et al. The emergence of attention deficits in early childhood: a prospective study. J Dev Behav Pediatr 1985;6:339–348.
720. Stewart MA, Thach BT, Freidin MR. Accidental poisoning and the hyperactive child. Dis Nerv Syst 1970;31:403–407.
721. Gerring JP, Brady KD, Chen A, et al. Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Acad Child Adolesc Psychiatry 1998;37:647–654.
722. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry 1997;36:1036–1045.
723. Biederman J, Mick E, Faraone SV, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159:36–42.
724. Porrino LJ, Rapoport JL, Behar D, et al. A naturalistic assessment of the motor activity of hyperactive boys. I. Comparison with normal controls. Arch Gen Psychiatry 1983;40:681–687.
725. Pelham W, Bender NE. Peer relationships in hyperactive children: description and treatment. Adv Behav Disabil 1982;1:365–435.
726. Levine MD, Oberklaid F, Meltzer L. Development output failure: a study of low productivity in school-age children. Pediatrics 1981;67:18–25.
727. Cantwell DP, Satterfield JH. The prevalence of academic underachievement in hyperactive children. J Pediatr Psychol 1978;3:168–197.
728. Lambert NM, Sandoval J. The prevalence of learning disabilities in a sample of children considered hyperactive. J Abnorm Child Psychol 1980;8:33–50.
729. Ackerman PT, Dykman RA, Gardner MY. ADD students with and without dyslexia differ in sensitivity to rhyme and alliteration. J Learn Disabil 1990;23:279–283.
730. Nigg JT, Hinshaw SP, Carte ET, et al. Neuropsychological correlates of childhood attention-deficit/hyperactivity disorder: explainable by comorbid disruptive behavior or reading problems? J Abnorm Psychol 1998;107:468–480.
731. Barkley RA. Behavioral inhibition, sustained attention and executive function: constructing a unified theory of ADHD. Psychol Bull 1997;121:65–94.
732. Nigg JT. Is ADHD a disinhibitory disorder? Psychol Bull 2001;127:571–598.
733. Scheres A, Oosterlaan J, Geurts H, et al. Executive functioning in boys with ADHD: primarily an inhibition deficit? Arch Clin Neuropsychology 2004;19:569–594.
734. Kinsbourne M. Testing models for attention deficit hyperactivity disorder in the behavioral laboratory. In: Conners C, Kinsbourne M, eds. ADHD: attention deficit-hyperactivity disorder. Munich: MMV Medizin Verlag, 1990:51–70.
735. Teicher MH, Ito Y, Glod CA, et al. Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psychiatry 1996;35:334–342.
736. Kinsbourne M. Toward a model for the attention deficit disorder. In: Perlmutter M, ed. Minnesota symposia in child development. Hillsdale, NJ: Erlbaum, 1983:137–166.
737. Conners CK. Clinical use of rating scales in diagnosis and treatment of attention-deficit/hyperactivity disorder. Pediatr Clin North Amer 1999;46:857–870.
738. Zametkin A, Rapoport JL. The neurobiology of attention deficit disorder with hyperactivity: where have we come in 50 years? J Am Acad Child Adolesc Psychiatry 1987;26:676–686.
739. Bhatia MS, Nigam VR, Bohra N, et al. Attention deficit disorder with hyperactivity among paediatric outpatients. J Child Psychol Psychiatry 1991;32:297–306.
740. Wolraich ML, Hannah JN, Pinnock TY, et al. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996;35:319–324.
741. Szatmari P. The epidemiology of attention-deficit hyperactivity disorders. Child Adolesc Psychiatry Clin North Am 1992;1:361–371.
742. Wasserman RC, Kelleher KJ, Bocian A, et al. Identification of attentional and hyperactivity problems in primary care: a report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics 1999;103:E38.
743. Robinson LM, Skaer JL, Sclar DA, et al. Is attention deficit hyperactivity disorder increasing among girls in the U.S? Trends in diagnosis and the prescribing of stimulants. CNS Drugs 2000;16:129–137.
744. Lambert MC, Knight F, Taylor R, et al. Epidemiology of behavioral and emotional problems among children of Jamaica and the United States: parent reports for ages 6 to 11. J Abnorm Child Psychol 1994;22:113–128.
745. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization, 1992.
746. Prendergast M, Taylor E, Rapoport JL, et al. The diagnosis of childhood hyperactivity: a US-UK cross-national study of DSM-III and ICD-9. J Child Psychol Psychiatry 1988;29:289–300.
747. Hinshaw SP. On the distinction between attentional deficits/hyperactivity and conduct problems/aggression in childhood psychopathology. Psychol Bull 1987;101:443–463.
748. Stewart MA, Cummings C, Singer S, et al. The overlap between hyperactive and unsocialized aggressive children. J Child Psychol Psychiatry 1981;22:35–45.
749. Biederman J, Fararone SV, Laysey K. Comorbidity of diagnosis in attention-deficit hyperactivity disorder. Child Adolesc Psychiatry Clin North Am 1992;1:335–358.
750. NICHD early child care research network. Trajectories of physical aggression from toddlerhood to middle childhood. Monographs Soc Res Child Dev 2004;69:1–129.
751. Dennis M, Wilkinson M, Koski L, et al. Attention deficits in the long term after childhood head injury. In: Broman S, Michel ME, eds. Traumatic brain injury in children. New York: Oxford University Press, 1994.
752. Olson HC, Streissguth AP, Sampson PD, et al. Association of prenatal alcohol exposure with behavioral and learning problems in early adolescence. J Am Acad Child Adolesc Psychiatry 1997;36:1187–1194.
753. Astbury J, Orgill A, Bajuk B. Relationship between two-year behavior and neurodevelopmental outcome at five years of very low-birth-weight survivors. Dev Med Child Neurol 1987;29:370–379.
754. Klebanov PK, Brooks-Gunn J, McCormick MD. Classroom behavior of very-low-birth-weight elementary school children. Pediatrics 1994;94:700–708.
755. Krouse JP, Kaufman JM. Morphological anomalies in exceptional children: a review and critique of research. J Abnorm Child Psychol 1972;10:247–264.
756. Wasserman J, Wolf LE, LeFever F, eds. Adult Attention Deficit Disorder, Brain Mechanisms and Life Outcomes. Ann Ny Acad Sci 2001.
757. Lahey BB, Piacentini JC, McBurnett K, et al. Psychopathology in the parents of children with conduct disorder and hyperactivity. J Am Acad Child Adolesc Psychiatry 1988;27:163–170.
758. Hechtman L. Families of children with attention deficit hyperactivity disorder: a review. Can J Psychiatry 1996;41:350–360.
759. Biederman J, Faraone SJV, Keenan K, et al. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Amer Acad Child Adolesc Psychiatry 1990;29:526–533.
760. Epstein JN, Conners CK, Erhardt D, et al. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol 2000;28:595–599.
761. Faraone SV, Biederman J, Milberger S. An exploratory study of ADHD among second-degree relatives of ADHD children. Biol Psychiatry 1994;35:398–402.
762. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121–124.
763. Cook EHJ, Stein MA, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995;56:993–998.
764. Gill M, Daly G, Heron S, et al. Confirmation of association between attention-deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311–313.
765. Doughety DD, Bonab AA, Spencer TJ, et al. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999;354:2132–2133.
766. Zentall SS, Meyer MJ. Self-regulation of stimulation for ADD-H children during reading and vigilance task performance. J Abnorm Child Psychol 1987;15:519–536.
767. Filipek PA, Semrud-Clikeman M, Steingard RJ, et al. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997;48:589–601.
768. Castellanos FX, Giedd JN, Eckburg P, et al. Quantitative morphology of the caudate nucleus in attention-deficit hyperactivity disorder. Am J Psychiatry 1994;151:1791–1796.
769. Hynd GW, Hern KL, Novey ES, et al. Attention-deficit hyperactivity disorder and asymmetry of the caudate nucleus. J Child Neurol 1993;8:339–347.
770. Aylward EH, Reiss AL, Reader MJ, et al. Basal ganglia volumes in children with attention-deficit hyperactivity disorder. J Child Neurol 1996;11:112–115.
771. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002;288:1740–1748.
772. Baumgardner TL, Singer HS, Denckla MB, et al. Corpus callosum morphology in children with Tourette’s syndrome and attention-deficit hyperactivity disorder. Neurology 1996;47:1–5.
773. Semrud-Clikeman M, Filipek PA, Biederman J, et al. Attention-deficit hyperactivity disorder: magnetic resonance imaging morphometric analysis of the corpus callosum. J Am Acad Child Adolesc Psychiatry 1994;33:875–881.
773a. Mostofsky SH, Reiss AL, Lockhart P, et al. Evaluation of cerebellar size in attention-deficit hyperactivity disorder. J Child Neurol 1998;13:434–439.
774. Lou HC, Henriksen L, Bruhn P, et al. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1990;46:48–52.
775. Matochik JA, Liebenauer LL, King AC, et al. Cerebral glucose metabolism in adults with attention-deficit hyperactivity disorder after chronic stimulant treatment. Am J Psychiatry 1994;151:658–664.
776. Satterfield JH, Schell AM, Nicholas T, et al. Topographic study of auditory-event related potentials in normal boys and boys with attention deficit disorder with hyperactivity. Psychophysiology 1988;25:591–606.
777. Zametkin AJ, Liebenauer LL, Fitzgerald GA, et al. Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1993;50:333–340.
778. Lazzaro I, Gordon E, Whitmont S, et al. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin Electroencephalogr 1998;29:37–42.
779. Harter MR, Annelo-Vento L, Wood FB, et al. Separate brain potential characteristics in children with reading disability and attention deficit disorder. Brain Cogn 1988;7:115–140.
780. Robaey P, Breton F, Dugas M, et al. An event-related potential study of controlled and automatic processes in 6- to 8-year-old boys with ADHD. Electroencephalogr Clin Neurophysiol 1992;6:330–340.
781. Conners CK, March JS, Erhardt D, et al. Assessment of attention deficit disorders (ADHD): conceptual issues and future trends. J Psychoeduc Assess 1995;14:186–205.
782. Aylward EH, Whitehouse D. Learning disability with and without attention deficit disorders. In: Ceci SJ, ed. Handbook of cognitive, social, and neuropsychological aspects of learning disabilities. Hillsdale, NJ: Erlbaum Associates, 1986–1987:321–342.
783. March JS, Swanson JM, Arnold LE, et al. Anxiety as a predictor and outcome variable in the multimodel treatment study of children with ADHD (MTA). J Abnorm Child Psychol 2000;28:527–541.
784. Swanson J, Kinsbourne M, Roberts W, et al. A time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 1978;61:21–29.
785. Epstein JN, Erkanli A, Conners CK, et al. Relations between continuous performance test performance measures and ADHD behaviors. J Abnorm Child Psychol 2003;31:543–554.
786. Greenberg LM, Waldman I. Developmental normative data on the test of variables of attention. J Child Psychol Psychiatry 1993;6:1019–1030.
787. Epstein JN, Erkanli A, Conners CK, et al. Relations between continuous performance test measures and ADHD behaviors. J Abnorm Child Psychol 2003;31:543–554.
787a. Liss IN, Saulnier C, Fein D, Kinsbourne M. Sensory and attention abnormalities in autistic spectrum disorders. Autism, in press.
788. Kagan J, Reznick JS, Snidman N. Biological bases of childhood shyness. Science 1988;40:167–171.
789. Nuechterlein KM. Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and hyperactive children. J Abnorm Psychol 1983;92:4–28.
790. Tillman R, Geller B, Craney JL, et al. Relationship of parent and child informants to prevalent mania symptoms in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004;161:1278–1284.
791. Akiskal HS, Downs J, Jordan P, et al. Affective disorders in referred children and younger siblings of manic depressives. Arch Gen Psychiatry 1985;42:996–1003.
792. Leibenluft E, Charney DS, Towbin KE, et al. Defining clinical phenotypes of juvenile mania. Amer J Psychiatry 2003;160:430–437.
793. Geller B, Zimerman B, Williams M, et al. J Child Adolesc Psychopharmacology 2002;12:11–25.
794. Rickler KC. Episodic dyscontrol. In: Benson F, Blumer A, eds. Psychiatric aspects of neurologic disease, Vol II. New York: Grune & Stratton, 1982.
795. Swedo SE, Leonard HL, Kiessling L. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics 1994;93:323–326.
796. Yeates KO, Bornstein RA. Attention deficit disorder and neuropsychological functioning in children with Tourette’s disorder. Neuropsychology 1994;8:65–74.
797. Channon S, Pratt P, Robertson MM. Executive function, memory and learning in Tourette’s syndrome. Neuropsychology 2003;17:247–254.
798. American Academy of Pediatrics Committee on Children with Disabilities and Committee on Drugs. Medication for children with attentional disorders. Pediatrics 1996;98:301–304.
799. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24 months outcomes of treatment strategies for attention-deficit hyperactivity disorder. Pediatrics 2004;113:754–761.
800. McDaniel KD. Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents, Part 1. Clin Pediatr (Phila) 1986;25:65–71.
801. Barkley RA. Hyperactive boys and girls: stimulant drug effects on mother-child interactions. J Child Psychol Psychiatry 1989;30:379–390.
802. Schachar R, Taylor E, Wieselberg M, et al. Changes in family function and relationships in children who respond to methylphenidate. J Am Acad Child Adolesc Psychiatry 1987;26:728–732.
803. Swanson JM, McBurnett K, Wigal T, et al. Effect of stimulant medication on children with attention deficit disorder: a “review of reviews.” Except Child 1993;60:154–162.
804. Volkow ND, Wang GJ, Fowler JS, et al. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. Am J Psychiatry 2004;161:1173–1180.
805. Lipkin PH, Goldstein IJ, Adesman AR. Tics and dyskinesias associated with stimulant treatment in attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 1994;148:859–861.
806. Rapport MD, duPaul GJ, Kelly KL. Attention-deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharm Bull 1989;25:285–290.
807. Greenhill LL, Abikoff HB, Arnold LE, et al. Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 1996;35:1–10.
808. Comings DE, Comings BG. Tourette’s syndrome and attention deficit disorder with hyperactivity. Arch Gen Psychiatry 1987;44:1023–1026.
809. Price RA, Leckman JF, Pauls DL, et al. Gilles de la Tourette’s syndrome. Tics and central nervous system stimulants in twins and non-twins. Neurology 1986;36:232–237.
810. Cohen AJ, Leckman JF. Sensory phenomena associated with Gilles de la Tourette. J Clin Psychiatry 1992;53:519–523.
811. Singer HS, Brown J, Quaskey S, et al. The treatment of attention-deficit hyperactivity disorder in Tourette’s syndrome: a double-blind placebo-controlled study with clonidine and desipramine. Pediatrics 1995;95:74–81.
812. Kilgore BS, Dickinson LC, Burnett CR, et al. Alterations in cartilage metabolism by neurostimulant drugs. J Pediatr 1979;94:542–545.
813. Croche AF, Lipman RS, Overall JE, et al. The effects of stimulant medication on the growth of hyperkinetic children. Pediatrics 1979;63:847–850.
814. Gittelman-Klein R, Mannuzza S. Hyperactive boys almost grown up. III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988;45:1131–1134.
815. Kalachnik JE, Sprague RL, Sleator EK. Effect of methylphenidate hydrochloride on stature of hyperactive children. Dev Med Child Neurol 1982;24:586–595.
816. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up. Changes in effectiveness and growth after the end of treatment. Pediatrics 2004;113:762–769.
817. Faraone SV, Wilens T. Does stimulant treatment lead to substance abuse disorder? J Clin Psychiatry 2003;64[Suppl]11:9–13.
818. Volkow ND, Wang GJ, Fowler JS, et al. Dopamine transporter occupanciees in the human brain induced by therapeutic doses of oral methylphenidate. Amer J Psychiatry 1999;155:1325–1331.
819. Greenhill L, Beyer DH, Finkelstein J, et al. Guidelines and algorithms for the use of methylphenidate in children with attention deficit/hyperactivity disorder. J Attention Disord 2000;6:S89–S100.
820. Greenhill LL, Swanson JM, Vitiello B, et al. Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Amer Acad Child Adolesc Psychiatry 2001;40:180–187.
821. Funk JB, Chessare JB, Weaver MT, et al. Attention deficit hyperactivity disorder, creativity, and the effects of methylphenidate. Pediatrics 1993;91:816–819.
822. Feldman H, Crumrine P, Handen BL, et al. Methylphenidate in children with seizures and attention-deficit disorder. Am J Dis Child 1989;143:1081–1086.
823. Gross-Tsur V, Manor O, vander Meere J, et al. Epilepsy and attention deficit disorder: is methylphenidate safe and effective? J Pediatr 1997;130:40–44.
824. Wroblewski BA, Leary JM, Phelan AM, et al. Methylphenidate and seizure frequency in brain injured patients with seizure disorders. J Clin Psychiatry 1992;53:86–89.
825. Spencer T, Biedermark J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention deficit hyperactivity disorder. Arch Gen Psychiatry 2001;58:775–782.
826. Pelham WE, Swanson JM, Furman MB, et al. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiatry 1995;34:1504–1513.
827. Shevell M, Schreiber R. Pemoline-associated hepatic failure: a critical analysis of the literature. Pediatr Neurol 1997;16:141–146.
828. Marotta PJ, Roberts EA. Pemoline hepatotoxicity in children. J Pediatr 1998;132:894–897.
829. Greenhill LL. Pharmacotherapy: stimulants. Child Adolesc Psychiatry Clin North Am 1992;1:411–447.
830. Chappell PB, Riddle MA, Scahill L, et al. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette’s syndrome: preliminary clinical experience. J Am Acad Child Adolesc Psychiatry 1995;34:1140–1146.
831. Swanson JM, Flockhart D, Udrea D, et al. Clonidine in the treatment of ADHD: questions about safety and efficacy. J Child Adolesc Psychopharmacol 1995;5:301–304.
832. Balldin J, Berggren U, Erikson E, et al. Guanfacine as an alpha-2-agonist inducer of growth hormone secretion: a comparison with clonidine. Psychoneuroendocrinology 1993;18:45–55.
833. Michelson D, Farris D, Wernicke J, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder a randomized, placebo-controlled dose-response study. Pediatrics 2001;108:E83.
834. Kelsey DK, Sumner CR, Casat CD, et al. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder including an assessment of evening and morning behavior: a double-blind placebo-controlled trial. Pediatrics 2004;63:114. e1-e8.
835. Kratochvil CJ, Heiligenstein JH, Dittmann R, et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolescent Psychiatry 2002;41:776–784.
836. Biederman J, Gastfriend DR, Jellinek MS. Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986;6:359–363.
837. Gammon GD, Brown TE. Fluoxetine and methylphenidate in combination for treatment of attention deficit disorder and comorbid depressive disorder. J Child Adolesc Psychopharmacol 1993;3:1–10.
838. Popper CW. Antidepressants in the treatment of attention-deficit hyperactivity disorder. J Clin Psychiatry 1997;58:14–29.
839. Wolf SM, Forsythe A. Behavior disturbance, phenobarbital, and febrile seizures. Pediatrics 1978;61:728–731.
840. Stein MA, Krasowski M, Leventhal BL, et al. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Arch Pediatr Adolesc Med 1996;150:284–288.
841. Christakis DA, Zimmerman FJ, DiGiuseppe DL, et al. Early television exposure and subsequent attentional problems in children. Pediatrics 2004;113:708–713.
842. Feingold BF. Why your child is hyperactive. New York: Random House, 1975.
843. Swanson JM, Kinsbourne M. Food dyes impair performance of hyperactive children on a laboratory learning test. Science 1980;207:1485–1487.
844. Egger J, Carter CM, Graham PJ, et al. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1985;1:540–545.
845. Kaplan BJ, McNicol J, Conte RA, et al. Dietary replacement in preschool-aged hyperactive boys. Pediatrics 1989;83:7–17.
846. Egger J, Stolla A, McEwen LM. Controlled trial of hyposensitization in children with foot induced hyperkinetic syndrome. Lancet 1993;341:114–115.
847. Kinsbourne M. Sugar and the hyperactive child. N Engl J Med 1994;330:355–356.
848. Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995;274:1617–1621.
849. Conners CK, Blouin AG. Nutritional effects on behavior of children. J Psychiatr Res 1982;17:193–201.
850. Shaywitz BA, Sullivan CM, Anderson GM, et al. Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics 1994;93:70–75.
851. Satterfield JM, Satterfield BT, Schell AM. Therapeutic interventions to prevent delinquency in hyperactive boys. J Am Acad Child Adolesc Psychiatry 1987;26:56–64.
852. Abikoff H, Hechtman L, Klein RG, et al. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry 2004;43:820–829.
853. Klein RG, Abikoff H, Hechtman L, et al. Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD. J Am Acad Child Adolesc Psychiatry 2004;43:792–801.
854. Barkley RA. Attention deficit hyperactivity disorder: a handbook for diagnosis and treatmen, 2nd ed. New York: Guilford Press, 1996.
855. Pelham WEJ, Carlson C, Sams SE, et al. Separate and combined effects of methylphenidate and behavior modification on boys with attention-deficit hyperactivity disorder in the classroom. J Consult Clin Psychol 1993;61:506–515.
856. Abikoff H. Cognitive training in ADHD children: less to it than meets the eye. J Learn Disabil 1991;24:204–209.
857. Wilens TE, McDermott SP, Biederman J, et al. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cogn Psychotherapy 1999;13:215–226.
858. Braswell L, Bloomquist ML. Cognitive-behavioral therapy with ADHD children: child, family and school interventions. New York: Guilford, 1991.
859. Swanson JM. School-based assessments and interventions for ADD students. Irvine, CA: KC Publications, 1992.
860. Latham P, Latham P. Who has a disability under the ADA? Attention 1999;6:40–42.
861. Roy-Byrne P, Scheele L, Brinkley J, et al. Adult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic. Compr Psychiatry 1997;38:133–140.
862. Loney J, Kramer J, Milich R. The hyperactive child grows up: predictors of symptoms, delinquency, and achievement at follow-up. In: Gadow J, Loney J, eds. Psychosocial aspects of drug treatment for hyperactivity. Boulder, CO: Westview, 1981:381–415.
863. Tarter RE, Alterman Al, Edwards KL. Vulnerability to alcoholism in men: a behavior-genetic perspective. J Stud Alcohol 1985;46:329–356.
864. Linnoila VI, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;53[Suppl]:46–51.
865. Marcus J, Hans SL, Nagler S, et al. Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study. Schizophr Bull 1987;13:425–438.
866. Schweitzer JB, Lee DO, Handford RB, et al. Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder: normalization of behavior but not related brain activity. Biol Psychiatr 2004;56:597–606.